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ABSTRACT 
 
 
 The selective activation of genes is essential for diverse biological processes such 
as growth, development, and responses to environmental cues.  Unlike lower organisms 
that often use individual proteins to control gene activation, transcription regulation in 
higher organisms generally requires cooperation among multiple proteins.  Cooperation 
can be achieved via interactions between DNA-binding proteins that bind to adjoining 
DNA sequences.  Such interactions can stabilize DNA binding by these proteins.  Many 
eukaryotic transcription factors form heterodimers that can bind to DNA in two opposite 
orientations. Because of the asymmetry of such heterodimers, cooperative DNA binding 
has been predicted, and in some cases observed, to require a specific orientation of 
heterodimer binding.  
 Interferon regulatory factor 3 (IRF3) and a heterodimer containing activating 
transcription factor 2 and c-Jun (ATF2-Jun) bind cooperatively to the human interferon-β 
enhancer, and opposite orientations of ATF2-Jun binding have been observed using 
different experimental approaches.  High mobility group protein I (HMGI) binds to 
sequences overlapping the ATF2-Jun-IRF3 site within the interferon-β enhancer and 
facilitates DNA-binding and synergistic transcriptional activation by components of the 
enhancer complex, yet its effects on ATF2-Jun-IRF3 complex formation have not been 
investigated. This thesis presents the identification of the structural determinants of 
ATF2-Jun heterodimer orientation at the interferon-β enhancer in vitro as well as 
 xii
functional characterization in cells.  Using gel-based fluorescence resonance energy 
transfer analysis, I found that ATF2-Jun binds to the interferon-β enhancer in both 
orientations alone and in association with IRF3 and HMGI.  Two symmetry-related sets 
of amino acid residues in ATF2 and Jun facilitated the opposite orientations of 
heterodimer interactions with IRF3 at the interferon-β enhancer. Expression of ATF2 and 
Jun variants that bound the interferon-β enhancer in opposite orientations together with 
IRF3 produced distinct levels of interferon-β transcription in Sendai-virus infected Hela 
cells.  Expression of these proteins resulted in different relative levels of transcription of 
different genes regulated by ATF2 and Jun.  Collectively, this work illustrates a novel 
mode of cooperative DNA-binding by transcription factors and suggests that alternative 
nucleoprotein arrangements can influence transcriptional activity through distinct 
mechanisms at different genes. 
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CHAPTER 1: INTRODUCTION 
 
 
 
I.  LITERATURE BACKGROUND 
 
 
 
I.A.  Cooperative DNA-binding by adjacent transcription factors 
 
 
 
 The regulation of gene activation is essential for diverse biological processes such 
as growth, development, and responses to environmental cues.  One of the central 
problems in understanding the regulation of gene activation is to explain how specific 
genes are selected for activation.  In lower organisms, the specification of gene activation 
is largely dependent on sequence-specific transcription factors which bind to gene-
specific DNA sequences in response to environmental cues.   Despite the enormous 
expansion of genome size during evolution, however, the sequence-specificity of 
transcription factors has not increased on average (4, 46).  In higher organisms, multiple 
transcription factors must cooperate to specify gene activation.      
 There are numerous mechanisms whereby transcription factors can cooperate.  
Transcription factors that bind adjacent sites can interact with each other in order to 
increase the specificity of DNA binding.  This cooperative specification of DNA-binding 
can involve either direct or indirect interactions between transcription factors.  Direct 
interactions, such as those between dimerizing transcription factors, can be obligatory for 
DNA binding.  Autonomous DNA-binding factors can also engage in interactions, such 
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as those required for cooperative ternary complex formation.   In all cases, interactions 
between adjacent transcription factors appear to be largely dependent on the spatial 
relationship between their cognate DNA recognition elements, allowing variations in the 
regulatory sequences of different genes to specify a particular transcription factor 
complex with distinct physical and functional attributes.  Although these facets of 
transcription factor cooperativity are certainly not the only ones governing the specificity 
of eukaryotic gene regulation, they represent an important aspect of how multiple 
transcription factor can come together to exert diverse functional effects. 
 
I.A.i.  Pair-wise interactions 
   
 The formation of large families of dimerizing transcription factors is one way in 
which a wide variety of DNA motifs can be recognized in higher organisms.  Members of 
these families can interact directly or indirectly with related or unrelated proteins in order 
to create homo- and heterodimeric complexes with unique DNA-binding specificities.  
Direct interactions often involve so-called “coiled-coil” interactions which mediate the 
coiling of one alpha helix around another.  Proteins which ulitize this interaction interface 
typically cannot otherwise bind to DNA as monomers.  Dimerizing interactions between 
transcription factors can involve many other types of interfaces as well, including other 
types of direct protein-protein interactions as well as mutually favorable distortions in the 
DNA structure. These interactions give rise to complexes that recognize a larger 
repertoire of DNA sequences and regulatory proteins.   Pair-wise interactions among 
transcription factors are therefore a simple mechanism of increasing the specificity of 
DNA recognition by a limited group of proteins. 
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I.A.i.a.  Direct dimerization interactions 
 
 The nuclear receptor superfamily of transcription factors illustrates the regulatory 
power of dimerization interactions among a related group of proteins.   Nuclear receptors 
bind to hormone response elements composed of two hexad repeats.  The individual 
hexamers can exist in different relative orientations with variable spacing between them, 
creating different types of hormone response element motifs (93).  One member of the 
nuclear receptor family, the retinoid X receptor, can dimerize with many other members 
of the nuclear receptor family to form different heterodimers which preferentially interact 
with direct hexad repeats spaced by a different number of nucleotides (39, 44, 85, 96) 
[Fig. 1.1].   A change in one nucleotide in the spacer region requires the 
heterodimerization partner to be rotated by approximately 36° around relative to the 
retinoid X receptor and translated by 3.4 Å along the double helix in order for 
dimerization and binding to occur (39, 44, 85, 94, 96).  Thus, the recognition of different 
hormone response element variants by different nuclear receptor heterodimers 
exemplifies how transcription factor dimerization can contribute to the increased 
specificity of DNA recognition in higher organisms. 
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Fig. 1.1. Binding of nuclear hormone receptor heterodimers to hormone response elements.  The 
retinoid X receptor (RXR, blue) dimerizes with itself, retinoic acid receptor (RAR), vitamin D receptor 
(VDR), and thyroid hormone receptor (TR) at hormone response elements (5’-AGGTCA-3’, yellow) 
spaced by a variable number of nucleotides (n).  A change in one nucleotide in the spacer region requires 
the heterodimerization partner (red) to be rotated by approximately 36° around relative to the retinoid X 
receptor and translated by 3.4 Å along the double helix in order for dimerization and binding to occur 
Retinoid X receptor and its partner, therefore, requires a succession of interaction surfaces or contortions in 
order for recognition of hexad repeats spaced by a progressively greater number of nucleotides.  
 
 
 
 Rules that determine transcription factor pairing in other heterodimeric complexes, 
however, are more complex.  Sox proteins are known to interact with various POU 
proteins, and their genes are involved in the determination of cell fate (5, 53). The highly 
conserved DNA-binding region of Sox proteins have a limited ability to bind to specific 
target sites, and heterodimerization with POU proteins provides a potential basis for how 
they can distinguish their targets. Heterodimers formed by the Sox-2 and the POU family 
protein Oct-4 can interact at two distinct recognition elements, FGF4 and UTF1, with 
different degrees of cooperativity.  The FGF4 enhancer contains a three base-pair spacer 
between the POU- and Sox-binding sites, whereas the UTF1 enhancer contains no spacer.  
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Comparison of the structures of Oct-4-Sox-2-FGF4 complex with an Oct1-Sox-2-UTF1 
complex has revealed the distinct modes of POU-Sox interaction.  In particular, the 
different protein-protein interaction interfaces are formed by different Sox surfaces which 
interact with the same surface of Oct proteins (89, 103).   These divergent cooperative 
DNA-binding mechanisms have been proposed to allow different subsets of genes to 
respond differentially to the cellular levels of Oct-4 and Sox-2.  Thus, distinct modes of 
POU-Sox dimerization can contribute to the selective regulation of different genes by the 
same transcription factor complex.     
 
I.A.i.b.  Indirect interactions 
 
The formation of transcription factor dimers can require interactions in addition to 
direct protein-protein contacts.  Heterodimers composed of the hematopoietic-specific Ets 
family transcription factor PU.1 and the lymphoid-restricted transcription factor 
interferon regulatory factor 4 (IRF4) bind to the enhancers of several light chain genes in 
B cells (29, 79).  Whereas PU.1 potentiates the binding of IRF4 or the related protein, 
IRF8, to DNA, it exhibits an anti-cooperative interaction with IRF1 and IRF2 (31).  A 
significant part of the cooperativity between PU.1 and IRF4 is mediated by the DNA-
binding domains. Electrophoretic mobility shift assay and quantitative hydroxyl radical 
footprinting studies have shown that the binding affinity of the IRF4 DNA binding 
domain increases between 5- and 40-fold in the presence of the PU.1 DNA-binding 
domain (31, 42, 104). The structure of the DNA binding domains of PU.1 and IRF4 on a 
composite DNA element revealed that DNA-bending by PU.1 and IRF4 contribute to 
PU.1-IRF4 cooperativity such that the binding of one transcription factor will aid the 
binding of the other by helping to configure the DNA around it (31).  Furthermore, this 
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configuration positions PU.1 and IRF4 for interactions involving amino acids specific to 
IRF4 and IRF8 (31). Together, protein-protein and indirect DNA-bending interactions 
contribute to the basis of selective cooperativity between PU.1 and IRF transcription 
factors. 
 
I.A.ii.  Ternary complex formation 
 
Higher-order complexes formed by adjacent DNA-binding proteins can further 
increase the selectivity of transcription factor-dependent transcription regulation.  A 
handful of crystal structures of multiprotein transcription factor complexes at composite 
regulatory elements have been solved including the MAT-α-MCM, SAP-1-SRF, and 
Fos-Jun-NFAT complexes (15, 45, 70, 98). Several features common to these complexes 
may also apply to other higher-order complexes and can explain cooperative DNA 
binding by transcription factors at composite regulatory elements. The interactions 
between cooperating DNA-binding proteins frequently involve regions in a close 
proximity to DNA. Thus, the DNA binding domains alone can be sufficient for 
cooperative complex formation at composite regulatory elements. Transcription factor 
binding to adjacent sites can create an uninterrupted protein-DNA interface extending 
across both recognition elements, thereby increasing the specificity and affinity of DNA 
binding. The DNA and protein conformations are often altered to form the protein-
protein and protein-DNA interaction interfaces. These conformational rearrangements 
may contribute to the selectivity of multiprotein complex formation. 
 Multiprotein transcription factor complexes at composite recognition elements 
can have a significant role in human disease states.  The formation of fusion proteins 
composed of the amino terminus of EWS (Ewing’s sarcoma) protein attached to the 
 6
DNA-binding and carboxy-terminal region of Ets family proteins correlate with the 
unchecked control of gene expression during Ewing’s sarcoma (67). Some EWS-Ets 
target genes, such as uridine phosphorylase, contain adjacent binding sites for Ets and 
AP-1 proteins. It has been shown that Ets family proteins that participate in Ewing's 
sarcoma, including Fli1, ERG, and ETV1, cooperatively bind these tandem elements with 
Fos-Jun while other Ets family members do not (56). Analysis of cooperativity between 
Fos-Jun and EWS-Fli1 fusion proteins in vitro showed that the DNA-binding domains of 
Fos and Jun and Fli1 are important for cooperative DNA binding (56). Whereas EWS-
Fli1 activates the expression of UPP mRNA, is directly bound to the UPP promoter, and 
transforms 3T3 fibroblasts, a truncated form of EWS-Fli1 that cannot cooperatively bind 
DNA with Fos-Jun is defective in all of these properties (56). Thus, the ability of EWS-
Ets proteins to cooperatively bind DNA with Fos-Jun mediates to the functional activities 
of these proteins and potentially the pathogenesis of Ewing's sarcoma. 
 
 
I.B.  Enhanceosomes 
 
 
 Interactions among adjacent transcription factors which are required for 
cooperative DNA-binding tend to require a specific arrangement of transcription factors 
at enhancer sequences.  This arrangement may serve a purpose beyond merely permitting 
interactions among the transcription factors themselves.  Specifically, the stereo-specific 
arrangement of transcription factors at enhancers is thought to act as a “docking” surface 
for co-activator proteins that can modify chromatin or recruit of general transcription 
machinery to the promoter.   These higher-order nucleoprotein structures have been 
referred to as “enhanceosomes.”   Whereas some enhancer sequences specify a compact 
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and precise organization of transcription factors characteristic of the classical 
enhanceosome, others have been proposed to include an extended arrangement with a 
variable group of proteins.          
 Enhanceosomes that embody both of these models have been identified and 
characterized.  The interferon-β and T-cell receptor-α enhanceosomes, for example, 
activates transcription only in response to stimuli that activate a specific group of 
transcription factors which must be organized in a specific arrangement at the enhancer 
(6, 21, 58, 68).  Architectural proteins high mobility group I (HMGI) and lymphoid 
enhancer-binding factor 1 (LEF-1) influence the assembly of transcription factors at the 
interferon-β and T-cell receptor-α enhanceosome, respectively (9, 21, 58, 106).  In 
contrast, the tumor necrosis factor-α enhanceosome can activate transcription in response 
to multiple signals through different sets of transcription factors which bind to the 
enhancer in different arrangements in response to different signals (33, 101, 102). 
However, inducer-specific enhanceosomes that are formed have different helical phasing 
requirements, indicating that the three-dimensional structure of these enhanceosomes is 
distinct (7, 102).   Therefore, flexible enhanceosome arrangements do not necessarily 
obviate a role for nucleoprotein architecture in cooperative interactions with co-activator 
proteins and general transcription machinery.   
 
 8
  
 
Fig. 1.2. Comparison of the formation of enhanceosome complexes at the T-cell receptor-α versus 
interferon-β enhancers.  Left panel: The binding of the architectural protein LEF-1 to the T-cell receptor-
α enhancer results in a 120° bend that is required for the assembly of an enhanceosome structure.  The 
specific three-dimensional surface of the enhanceosome (dotted line) is required for efficient recruitment of 
the co-activator protein ALY along with the RNA Pol II holoenzyme.  Right panel:  The binding of the 
architectural protein HMGI to the interferon-β enhancer reduces an intrinsic 20° bend that is required for 
the assembly of an enhanceosome structure.  The specific three-dimensional surface of the enhanceosome 
(dotted line) is required for efficient recruitment of the co-activator protein CBP along with RNA Pol II as 
well as reciprocal cooperative-DNA binding interactions with a sub-complex composed of TFIIA (IIA), 
TFIIB (IIB), TFIID (IID), TATA-binding protein (TBP), and the USA co-activator.     
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I.B.i.  Role of architectural proteins 
 
 Although many of the sequence-specific transcription factors comprising the 
enhanceosome are traditional activator proteins, DNA-bending or “architectural” proteins 
can also contribute to transcriptional activation by facilitating interactions between 
activator proteins that bind to separate recognition elements (9, 87, 95).  The interferon-β 
and the T-cell receptor-α enhanceosomes employ architectural proteins HMGI and LEF-
1, respectively, to mediate cooperative binding of activators.  HMGI and LEF-1 are 
sequence-specific DNA-bending proteins from two distinct classes of chromatin-
associated high mobility group (HMG) proteins.  Unlike LEF-1, which contains an 
activation domain, HMGI does not participate directly in stimulation but does facilitate 
cooperative assembly of the enhanceosome (58).      
 HMGI protein contains three repeated basic DNA-binding domains separated by 
short linkers.  At least two of the domains simultaneously interact with the minor groove 
of different AT-rich sequences in the enhancer (105). The current idea is that the HMGI 
reverses a mild, yet inhibitory, 20° DNA bend toward the minor groove and facilitating 
the binding of transcription factors with an intrinsic preference for un-bent DNA (35, 55, 
106).  LEF-1 contains a conserved HMG domain, also found in the ubiquitous HMG-1 
and -2 proteins, which binds in the minor groove and intercalates a hydrophobic amino 
acid between adjacent base pairs in the site (87). The HMG domain bends and untwists 
the DNA, molding the minor groove to fit the contour of the protein (38, 65). The 
resulting 120° bend permits cooperative interactions between other transcription factors 
at the T-cell receptor-α enhancer (37).  
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 Specific regions of HMGI can undergo conformational changes upon interactions 
with proteins and DNA (88). This flexibility permits HMGI to participate in diverse 
biological processes ranging from transcription regulation to DNA recombination (19, 86, 
88). In addition, phosphorylation and acetylation can modulate interactions involving 
HMGI (19). For example, in the context of the interferon-β enhanceosome, lysine 
acetylation of HMGI by the co-activator PCAF enhances the affinity of HMGI for other 
transcription factors and induces enhanceosome assembly (71).  By contrast, acetylation 
by CBP on a distinct lysine residue results in detachment of the protein from the DNA 
leading to enhanceosome disruption and subsequent termination of interferon-β 
transcription (71, 72).  These observations suggest that architectural proteins can function 
as the sensitive molecular switch required for both enhanceosome assembly and 
disassembly.  Examination of the roles played by LEF-1 and HMGI in different 
enhanceosomes will determine whether their functions can be generalized or are context 
specific. 
 
I.B.ii.  Cooperative interactions with general factors  
 
 In addition to cooperative DNA-binding interactions among transcription factors, 
enhanceosomes utilize additional mechanisms of cooperativity to enrich the specificity of 
transcriptional activation.  Numerous studies have revealed interactions between 
enhancer-bound transcription factors and the general factors (1, 7, 12, 57, 62, 63, 68, 107).  
In certain contexts, cooperative DNA-binding among these complexes facilitates the 
recruitment of general factors to specific genes, which also further stabilizes the 
enhanceosome itself (7, 57).  The concerted association of multiple transcription factors 
with either co-activators or general factors has been proposed to underlie additional 
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mechanisms enhanceosome cooperativity, directly facilitating the recruitment of 
chromatin-modifying proteins and RNA polymerase II to nearby promoters.  A specific 
activation surface has been proposed to mediate the cooperative recruitment of co-
activator complexes by enhanceosomes (7, 10, 12, 58, 68, 102), although applicability of 
these architectural requirements to endogenous enhanceosomes for these and other genes 
remains to be determined.    
 
I.B.ii.a.  Reciprocal DNA-binding interactions 
 
 A model in which the enhanceosome engages in multiple, specific contacts with 
the general machinery predicts that those interactions will reciprocally stabilize the 
assembly of the enhanceosome.  In vitro transcription experiments by Kim and Maniatis 
have demonstrated that, when the interferon-β enhanceosome was pre-incubated with 
TFIIA, TFIIB, TFIID, and the USA co-activators, a transcription complex resistant to the 
detergent sarkosyl as well as competitor oligonucleotides was formed (57).  The TFIIE, 
TFIIF, TFIIH, and Pol II fractions, which apparently contain CBP, further increase the 
stability (57). A more direct reciprocal effect was observed with the co-activator ALY, 
which dramatically enhanced cooperative binding of LEF-1 and AML-1 to the T-cell 
receptor-α enhancer in DNase I footprinting experiments (12). Other studies have shown 
that the magnitude of the reciprocity is dependent upon the strengths of the activator–
target interactions (99).  This effect has been proposed to provide the additional 
specificity and energy necessary to drive the concerted formation of the final pre-
initiation complex in the face of the large energetic obstacle posed by chromatin (59).  
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I.B.ii.b.  Stereo-specific interactions 
Transcription factors need not bind cooperatively to DNA in order to 
synergistically activate transcription. Experiments from the Maniatis lab using 
mammalian nuclear extracts depleted of endogenous interferon-β enhancer-binding 
proteins and supplemented with recombinant proteins have shown that the absence or 
repositioning of individual transcription factor binding sites within the interferon-β 
enhancer abolished cooperative activation of reporter gene plasmids even when the 
proteins were present at saturating concentrations (58).  This type of cooperativity among 
multiple transcription factors has been portrayed as a specific activation surface that is 
chemically and spatially complementary to surfaces on co-activator and the general 
transcription machinery [Fig 1.2].   
This model has been supported by other studies from the Maniatis lab which 
revealed that the activating surface of the interferon-beta enhanceosome displays a high 
specificity for the co-activator CBP (68).  Removal of the individual transcription factor 
activation domains, replacement of activation domains with VP16, or altered helical 
phasing of the binding sites, abolished cooperative CBP-dependent transcriptional 
activation in vivo and the efficient assembly to the enhanceosome in vitro (68). Deletion 
analysis suggested that the p65 subunit of NF-kB contains specific domains which 
mediate interactions with either CBP or general transcription factors (33, 68).  Studies 
have also shown a requirement for CBP in tumor necrosis factor-α transcription in the 
context of chromatin (33). A different co-activator called ALY interacts specifically with 
the combination of LEF-1 and AML-1 at the T-cell receptor-α enhancer (12).  Taken 
together, these data suggest that specific identities and arrangements of transcription 
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factors can cooperatively increase the affinity of co-activators and general machinery for 
the enhanceosome through direct interactions.       
Studies with other systems have also suggested that interactions between 
transcription factors and the general machinery can lead to cooperative activation of 
transcription.  Multiple molecules of the Ebstein-Barr virus-specific transcription factor 
ZEBRA activate reporter gene transcription in a greater-than-additive fashion.  ZEBRA-
dependent activation, however, is highest with only two or three upstream binding sites, 
suggesting that recruitment of a limited set of auxillary regulatory proteins is sufficient 
for the effect (13).  In contrast, Fos-Jun heterodimers fused to one or two GCN4 
activation domains have been shown to activate reporter gene transcription equally well 
at sequences containing two tandem AP-1 sites (75), suggesting that the DNA-binding 
domains rather than the acidic activation regions are the principal determinant of 
transcriptional synergy.           
 The notion that contacting a limited repertoire of targets is sufficient for activation 
has derived support mainly from studies in yeast. The tethering of the DNA-binding 
protein LexA to any one of several different components of the general machinery (TBP, 
TFIIB, TAFs, or GAL11) was shown to be sufficient for transcriptional activation (80). 
These data imply that individual general factors, when recruited to a promoter, have the 
capacity to nucleate assembly of a functional transcription complex. Therefore, although 
the total mass of the complex in mammalian cells has been estimated to exceed 2.5 MDa 
and contain dozens of polypeptides, transcription factors may only interact with only a 
small portion of the overall surface, or a few targets within it, to stimulate transcription.  
However, unlike the case of LexA-co-activator fusions in yeast, the tethering of other co-
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activators such as CBP or ALY to DNA-binding proteins does not bypass the function of 
transcription factors (12, 68).  Therefore, the concept of “stereo-specificity” in 
transcription factor interactions with co-activators and the general transcription 
machinery requires further investigation.   
 
I.B.iii.  Context-dependent dynamics 
 
 The arrival and departure of various regulatory factors often occur at 
enhanceosomes during transcriptional activation, suggesting some form of dynamics.  
The T-cell receptor-α enhanceosome assembles early in T-cell differentiation but remains 
inactive until T-cells enter the double-positive stage (50).  This suggests that the activity 
of the T-cell receptor-α enhanceosome is dynamically modulated by the recruitment of at 
least one stage-specific factor. Similarly, in B-cells, although RFX, NF-Y, and X2B 
transcription factors cooperatively bind MHC class II genes in a constitutive manner, 
activation occurs only when the class II transactivator protein is recruited to the 
preformed enhanceosome via a mechanism that is largely unknown (52, 66).  At the 
interferon-β enhancer, key transcription factors have been found to associate sequentially 
rather than simultaneously after Sendai virus infection (1, 71).   Comparisons of the 
biochemical details of enhanceosome formation in different contexts are required to 
reveal how enhanceosomes can be “adjusted” to accommodate alternate regulatory 
scenarios.   
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II.  bZIP PROTEINS IN TRANSCRIPTIONAL ACTIVATION 
 
 
Transcription regulation is thought to involve a myriad of nucleoprotein 
complexes in which the individual components play different roles in assembly and 
function of complexes at different genes. The basic region leucine zipper (bZIP) family 
of transcription factors functions in the assembly of these complexes. The bZIP family 
includes more than 70 proteins in humans that can cross-dimerize to potentially form 
hundreds of homo- and heterodimers expressed in a variety of cell types.  The diversity of 
bZIP complex formation allows cells to respond to many different extra-cellular signals 
during a wide range of physiological and pathological processes.   
 The bZIP family has been subdivided into classes of proteins based on DNA-
binding specificity or heterodimerization properties. Ternary complexes of bZIP homo- 
or heterodimers with other transcription factors allow responses to a variety of signals to 
which bZIP proteins alone do not respond.    bZIP complexes can also exert their effects 
by binding components of the transcription machinery, including subunits of the TFIID 
and mediator complexes as well as by recruiting chromatin modifying complexes.  
Therefore, numerous mechanisms whereby bZIP family proteins influence transcriptional 
regulatory specificity likely exist.  
 
II.A.  Dimerization and DNA binding 
 bZIP proteins take their name from a highly conserved basic region required for 
DNA binding and a heptad repeat of leucine residues, the leucine zipper, required for 
dimerization (3, 60, 73).  Since members of different bZIP protein subfamilies exhibit 
distinct DNA binding specificities, dimerization between different bZIP protein 
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subfamilies expands the repertoire of binding sites for bZIP family proteins to include 
sequences composed of different half-sites (43). Dimerization between different bZIP 
proteins at the same DNA sequence can further increases regulatory specificity by 
exerting different effects on transcriptional activation (20, 24).  
Formation of homo- and heterodimeric bZIP complexes through the leucine 
zipper symmetrically juxtaposes the two basic regions to form a DNA-contact interface in 
which the dimer subunits interact in opposite relative directions with the major grooves 
of adjoining half-sites (40).   Consequently, the DNA recognition sites for bZIP family 
proteins are all perfect or near-perfect palindromes.  Six major categories of DNA-
binding sites exist for bZIP proteins.  In metazoans, these include the TPA responsive 
element (AP-1), cAMP responsive element (CRE), CAAT box, AF recognition element, 
CRE-like, and PAR binding sites (23).   The bZIP family has been subdivided into 
classes of proteins based on their DNA-binding specificities and heterodimerization 
properties. Examples of such bZIP subfamilies include Fos/Jun, ATF/CREB, C/EBP, 
CNC, Maf, and Yap proteins (23).   
 The Fos/Jun/CREB/ATF families of bZIP proteins recognize a seven base-pair 
AP-1 site (5’-TGA(C/G)TCA-3’) and an eight base-pair CRE site (TGACGTCA). 
Although mutational analysis of the basic regions of Fos and Jun have shown that 
corresponding mutations in the two basic regions have similar effects on DNA binding 
(84), contacts made with asymmetric base pair substitutions in the AP-1 site are not 
always identical between Fos and Jun (40).  Even at recognition elements with 
symmetrical half-sites, UV-light crosslinking studies have suggested that there are some 
differences in the interaction of Fos and Jun with the left and right halves of the AP-1 site 
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(48, 90). Finally, binding-interference studies using base methylation and phosphate 
ethylation, as well as Fe2+-methidiumpropyl -EDTA protection studies, have shown that, 
though there is an overall symmetry in the interference patterns, there are local 
differences that indicate that the individual contacts made at the two half sites are not 
identical even for homodimeric complexes (74). Thus, while the global structure of the 
dimeric DNA-binding complex is relatively symmetric, there are local variations in 
structure between the two halves of the recognition complexes. 
The X-ray crystal structure of the Fos-Jun-AP-1 complex revealed that Fos-Jun 
heterodimers can bind the AP-1 site in two opposite orientations that are related by an 
approximately 180° rotation about the dimer axis [Fig. 1.3].  However, since not all Fos 
and Jun DNA-contacts are identical as described above, preferences for one orientation 
over the other can result from asymmetrical base substitutions within the core or flanking 
DNA recognition sequences (83). Consequently, Fos–Jun heterodimers bind to different 
AP-1 sites with different orientation preferences.   
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 Fig. 1.3. Co-crystalization of Fos-Jun heterodimers bound to the canonical AP-1 recognition site in 
opposite orientations.  Both Fos and Jun contact DNA, and the major DNA-contact sites are located 
within the major grooves of both halves of the recognition site.  The amino-terminal ends of the basic 
regions of Fos and Jun are located in the major grooves approximately five base pairs from the center of the 
binding site. Upon binding to DNA, the previously unfolded basic regions become a-helical such that five 
conserved amino acid residues are positioned to contact specific base pairs in the target sites.  The figure 
was created using the PyMOL Molecular Graphics System (22) and coordinates form the RCSB Protein 
Data Bank [www.pdb.org (8), PDB ID: 1FOS] in agreement with the published structure (40). 
 
 
II.B.  Interactions with other proteins  
 
 The selectivity of bZIP associations with unrelated proteins provides an additional 
mechanism for the specificity of transcriptional responses by bZIP proteins beyond that 
achieved by the heterodimerization properties of bZIP factors.  Ternary complexes of the 
bZIP homo- and heterodimers with other transcription factors allow the transcriptional 
activation function of bZIP proteins to be used in response to a variety of signals to which 
bZIP proteins alone does not respond.  The x-ray crystal structures of ternary complexes 
composed of the Fos-Jun heterodimer and nuclear factor of activated T-cells 1 (NFAT1) 
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at the interleukin-2 enhancer as well as the ATF2-Jun heterodimer and interferon 
regulator factor 3 (IRF3) at the interferon-β enhancer has been solved (15, 77).   For other 
proteins, such general transcription factors, co-activators, histones, or transcription 
factors belonging to the Smad, Stat, bHLH, EWS, and nuclear hormone receptor families 
interactions with bZIP proteins have been reported (2, 17, 47, 54, 56, 64, 69, 81) but 
remain largely undefined at the structural level.      
 The co-activator paralogues p300 and CBP contain acetyltransferase domains 
(HAT) and catalyze the lysine acetylation of histones and other proteins as an important 
aspect of their functions. Prior studies revealed that ATF2 can interact with the CBP 
HAT domain (91).  Examination of interaction between the bZIP domain of ATF2 with 
the HAT domain of p300 has shown that p300 HAT auto-acetylation can enhance the 
binding affinity (54). Pull-down assays revealed that hyper-acetylated p300 HAT is more 
efficiently retained by immobilized ATF2 bZIP domains than hypo-acetylated p300 HAT 
(54). Loop deleted p300 HAT lacking auto-acetylation was retained about as well as 
hyper-acetylated p300 HAT, suggesting that the loop and ATF2 compete for p300 HAT 
binding (54). While ATF-2 b-ZIP is a weak inhibitor of hypo-acetylated p300 HAT 
acetylation of a histone H4 peptide, hyper-acetylated p300 HAT is much more potently 
inhibited by the bZIP domain of ATF2 (54).    
 It has also been shown that the bZIP domain of ATF2 could serve as an 
acetylation substrate for p300. Using mass spectrometry, two p300 HAT lysine 
acetylation sites were mapped in ATF2 bZIP. Immunoprecipitation-Western blot analysis 
with anti-acetyl-lysine antibody revealed that ATF2 can undergo reversible acetylation in 
vivo (54). Mutational analysis of the two ATF2 bZIP acetylation sites revealed their 
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potential contributions to ATF2-mediated transcriptional activation (54). Taken together, 
these studies suggest multiple roles for protein acetylation in the regulation of 
transcription by p300/CBP and ATF2.     
 The transcriptional activation of CHOP (a CCAAT/ enhancer-binding protein-
related gene) by amino acid deprivation involves ATF2 and ATF4 binding to the amino 
acid response element (AARE) within the promoter. Using a chromatin 
immunoprecipitation approach, it was reported that in vivo binding of phospho-ATF2 and 
ATF4 to CHOP AARE correlates with acetylation of histones H4 and H2B in response to 
amino acid starvation (11). A time course analysis reveals that ATF2 phosphorylation 
precedes histone acetylation, ATF4 binding and the increase in CHOP mRNA (11). It 
was also shown that ATF4 binding and histone acetylation are two independent events 
that are required for the CHOP induction upon amino acid starvation (11). Using ATF2-
deficient mouse embryonic fibroblasts, it was demonstrated that ATF2 is essential in the 
acetylation of histone H4 and H2B at the endogenous CHOP locus (11). The role of 
ATF2 on histone H4 acetylation is dependent on its binding to the AARE and can be 
extended to other amino acid regulated genes (11). Thus, bZIP proteins can promote the 
modification of the chromatin structure to enhance transcriptional activation. 
 bZIP transcription factors can also interact with histone proteins during the 
maintenance of repressive chromatin states.  Transcriptional activation of the interleukin-
8 gene is restricted to specific cell types, although the transcriptional regulatory proteins 
controlling interleukin-8 gene expression are ubiquitous.  In expressing epithelial cells 
the enhancer/promoter is nucleosome-free, whereas in non-expressing B-cells, a 
nucleosome containing the histone variant macroH2A is formed at the interleukin-8 
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regulatory region.   Recruitment of the repressive macroH2A nucleosome requires direct 
interactions between ATF2 bound to the nearby AP1 site and macroH2A, and treatment 
with siRNA against ATF2 or macroH2A rescues IL-8 transcription in B cells (2).  
Substitution of the interleukin-8 enhancer ATF2 binding site with the IFN-b enhancer 
ATF2 binding site (PRDIV) abolishes macroH2A recruitment to the interleukin-8 
enhancer and results in reporter gene activation in B-cells, whereas replacement of 
PRDIV with the interleukin-8 enhancer ATF2 binding site recruits macroH2A to the IFN-
b enhancer and abolishes reporter gene activation in B-cells (2).  Thus, interactions 
between ATF2 and different recognition sites can have differential effects on local 
chromatin architecture that may depend on conformational-specific interactions with 
histone variants. 
 
I.C.  Consequences of oriented heterodimer binding 
 
 Since interactions between bZIP proteins and other proteins often require a 
particular spatial arrangement of proteins on DNA, the relative positions of bZIP proteins 
and other proteins at individual regulatory regions can, in turn, influence their 
interactions.   Differences in the conformation and positioning of DNA-bound bZIP 
proteins can be caused by differences in the sequence of the DNA recognition site.  
Asymmetric base substitutions in AP-1 sites which have opposite effects on the 
orientation of DNA-binding by Fos-Jun heterodimers have a potent effect on cooperative 
complex formation with NFAT1 and the efficiency of reporter gene activation (83).  In 
this way, the efficiency of transcriptional activation by Fos-Jun-NFAT complexes can be 
modulated in a gene-specific manner.  
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 The Fos-Jun-NFAT1 ternary complex bound to the ARRE2 site in the interleukin-
2 enhancer contacts a 15 base pair recognition element in which all the base pairs are 
contacted by either Fos-Jun or NFAT1 (15). The cooperative interaction between Fos-Jun 
and NFAT1 induces a DNA bend of approximately 20° toward the interaction interface 
(15, 25), which is required to bring NFAT1 and Fos-Jun together.  Both Fos-Jun and 
NFAT undergo conformational changes to form the interaction interface. The leucine 
zipper of the Fos-Jun heterodimer is tilted by approximately 15° toward NFAT1 [Fig. 
1.4].  NFAT1 forms an extensive interaction interface with the Fos-Jun heterodimer 
involving one face of the leucine zipper. The conformation of NFAT in the ternary 
complex may also change relative to the binary complex.  The interaction between 
NFAT1 and Fos-Jun is asymmetric and requires the binding of Jun to the half-site 
proximal to NFAT (15, 16, 25, 30, 78, 97).  Thus, alternative orientations of bZIP 
heterodimer binding at different recognition elements can differentially accommodate 
cooperative interactions with adjacent proteins resulting in diverse transcriptional outputs. 
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 Fig. 1.4.  Crystal structure of Fos-Jun-NFAT1-ARRE2 complex.  The figure was created using the 
PyMOL Molecular Graphics System (22) and coordinates form the RCSB Protein Data Bank 
[www.pdb.org (8), PDB ID: 1A02] in agreement with the published structure (40). 
 
 Reversal of the orientation of bZIP heterodimer binding at any one recognition 
element can potentially influence genes in a stage-specific manner. In this scenario, the 
presence of either alternative DNA-binding proteins or post-translational modifications 
within an interaction interface could influence the architecture and function multi-protein 
complexes in a temporal- and cell-type specific manner.   In support of the idea that the 
architecture of multi-protein complexes can influence transcriptional activation, 
repositioning of the activation domains of Fos-Jun heterodimers had a significant effect 
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on the efficiency of reporter gene activation in yeast independent of cooperation with 
NFAT1 (18).   In a more recent study, pharmacologic inhibitors of Jun phosphorylation 
which do not affect recruitment of Fos, Jun, or NFAT to the endogenous interleukin-2 
enhancer blocked a proposed “late phase” interleukin-2 enhancer activity including the 
binding of other transcription factors, the recruitment of CBP, and the acetylation of 
histone H3 at lysine 27 (51), indicating a potential role for regions outside of the DNA-
binding domain of Jun in interleukin-2 enhancer dynamics.   
 Like Fos-Jun-NFAT1, only single bZIP heterodimer orientation was observed in 
the crystal structure of ATF2-Jun-IRF3 at the interferon-β enhancer (77) [Fig. 1.5].  By 
analogy to Fos-Jun and NFAT1, it was hypothesized that asymmetric interactions 
between ATF2-Jun and IRF3 at adjacent sites are the driving force for cooperative DNA-
binding (77).  However, the ATF2-Jun-IRF3 structure gives little support for this 
hypothesis.  The only direct contact observed is between D45 of IRF3 (bound to 5’ 
PRDIII half-site) and R345 of ATF2 (bound to the PRDIV half-site).  R345A substitution 
in ATF2, however, had no detectable effect on complex formation with IRF3 at PRDIV-
III as reveal by gel-shift analysis (77).  Since Jun does not bind tightly to 3’ 
nonconsensus PRDIV half-site and IRF3 bends the DNA toward itself and away from Jun, 
the authors attributed cooperative DNA-binding to complementary DNA conformations 
induced by the binding of ATF2-Jun and IRF3.   
 Previous photo-crosslinking analysis of ATF2-Jun-IRF3 complexes indicated that 
cooperativity between ATF2-Jun and IRF3 at the interferon-β enhancer required a 
heterodimer orientation opposite from that observed in the crystal structure (34).  In a 
more recent study, comparison of the fluorescence polarization efficiency of end-labeled 
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oligonucleotides by ATF2 homodimers, Jun homodimers, versus ATF2-Jun heterodimers 
demonstrated that ATF2-Jun can bind to PRDIV in two orientations in the presence of 
IRF3 (26).   Thus, ATF2-Jun-IRF3 represents a complex in which two alternative bZIP 
heterodimer orientations have been observed at the same enhancer element.  Since the 
enhanceosome encompassing ATF2-Jun-IRF3 complexes has been described in detail, 
ATF2-Jun-IRF3 could provide a convenient model system to study the role of alternative 
bZIP heterodimer orientations in the dynamics of enhanceosome assembly and 
reorganization. 
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 Fig. 1.5.  Crystal structure of ATF2-Jun-IRF3-PRDIV-III complex. The figure was created using the 
PyMOL Molecular Graphics System (22) and coordinates form the RCSB Protein Data Bank 
[www.pdb.org (8), PDB ID: 1T2K] in agreement with the published structure (77). 
 
 
 
 
 
 
 
 
 27
III.  ATF2, JUN, IRF3, HMGI INTERACTIONS ON DNA 
 
 
III.A.  Protein-DNA interactions 
 
 The interferon-β enhancer consists of four positive regulatory domains (PRDs) 
which are numbered according to the chronological order in which the domains were 
discovered to confer reporter plasmid virus-inducibility (27, 36, 41, 61) [Fig. 1.6].  IRF 
proteins bind to PRDI and PRDIII, the NF-κΒ heterodimer p50-p65 binds to PRDII, and 
ATF2-Jun binds to PRDIV.  The downstream (3’) PRDIV half-site overlaps PRDIII, 
which is recognized by two IRF molecules.  PRDI is recognized by two additional IRF 
molecules. IRF3 preferentially recognizes the 5’ PRDIII and PRDI half-sites, whereas 
either IRF3 or IRF7 recognize the 3’ PRDIII and PRDI half-sites. PRDII, located 
immediately downstream of PRDI, is recognized by the p50-p65 NF-kB heterodimer.  
Flanking PRDIV and PRDII are two pairs of AT-rich sequences which are protected from 
DNase I digestion in the presence of HMGI (105).  Whereas p50-p65 binds PRDII in a 
fixed orientation, ATF2-Jun heterodimers have been found to bind to PRDIV in two 
opposite orientations using different experimental approaches (26, 34).  In an effort to 
identify factors that influence the orientation of ATF2-Jun at PRDIV, the binding of 
ATF2, Jun, IRF3, and HMGI at the PRDIV-III composite element have been the focus of 
several studies (14, 26, 28, 34, 77). 
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Fig. 1.6. Transcription factor binding sites within the interferon-β enhancer.  Binding sites 
assignments for subunits of the ATF2-Jun heterodimer (dotted lines), IRF3 (light green), IRF7 (dark green), 
p50 (yellow), and p65 (red), indicated by brackets, are based on x-ray crystallographic structures.  Binding 
sites assignments for an unknown number of HMGI molecules, indicated by brackets, are based on DNase I 
footprinting analysis.  The positions of positive regulatory domain (PRD) IV, III, I, and II are indicated by 
lines.    
 
 X-ray crystallography has revealed that ATF2-Jun heterodimers adopt a structure 
similar to that of Fos-Jun heterodimers (77) [Fig. 1.5].  The two proteins dimerize 
through a C-terminal leucine zipper, and the N-terminal basic regions lie in the major 
grooves of PRDIV recognition element.  ATF2-Jun binds to an 8-bp sequence (5′-
TGACATAG-3′) in PRDIV which differs from the canonical CRE site (5’-TGACGTCA-
3’) by three base substitutions (underlined) in the 3’ half-site.  Consensus bZIP-DNA 
interactions are observed in the 5’ half-site. An arginine-guanine contact, which is 
important for the binding of Fos-Jun heterodimers to the AP1 site (82), is observed in the 
consensus PRDIV half-site (77).  In contrast, base substitutions in the nonconsensus 3’ 
half-site appear to preclude optimal contacts between the basic region and the major 
groove.   Non-optimal binding to the 3’ half-site may be functionally important since the 
non-consensus recognition sequence is also observed in other organisms for which the 
surrounding the interferon-β enhancer sequence is strictly conserved with the exception 
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of several base pairs not included in enhancer binding-protein core recognition sequences 
(76).     
 Despite asymmetries in the sequence, ATF2-Jun heterodimers have been 
hypothesized to bind PRDIV in both orientations.  Using a UV-light-crosslinking 
approach, Falvo et al. showed that ATF2-Jun binds to PRDIV in two orientations (34).   
In an independent study, measurement of the fluorescence polarization efficiencies of 
FAM fluorophores conjugated to one end of PRDIV oligonucleotides revealed that the 
binding of ATF2 and Jun homodimers have significantly different effects on tumbling 
time, with ATF2-Jun heterodimers yielding a tumbling time intermediate of the two 
homodimer complexes (26). Since these relative effects do not correlate with slight 
differences in the DNA binding affinities of these dimeric complexes at PRDIV as 
measured by isothermal titration calorimetry (14, 26), these results have been attributed 
to the binding of ATF2-Jun to PRDIV in both orientations. 
 Overlapping and adjacent to the 3’ PRDIV half-site are two tandem IRF sites 
termed PRDIII.  IRF7 expression is increased through a positive feedback by IFN 
stimulation, whereas IRF3 is constitutively expressed in most cell types (92). These 
properties suggested that the immediate early enhanceosome might only contain IRF3 
and that IRF7 has a role in later stages of virus infection. Early work therefore focused on 
crystallizing the enhanceosome with IRF3 bound to the PRDIII region of enhancer.   It 
then became clear, however, that IRF7 is constitutively expressed at high levels in 
plasmocytoid dendritic cells, the primary source of type I interferon in response to 
infection, and that it is essential for IRF7 expression (49). A challenge for structural 
studies was then to understand which of four IRF-binding sites in PRDIII–I would 
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accommodate IRF7 and IRF3 as their positioning might be crucial for enhanceosome 
assembly.  A crystal structure suggests that IRF3 binds preferentially to the 5’ half-sites 
of PRDIII and PRDI whereas IRF7 binds to the 3’ half-site of PRDIII and PRDI [Fig. 1.6] 
(76).             
 In the ATF2-Jun-IRF3 crystal structure, two IRF3 molecules bind to the PRDIII 
region on opposite faces of the DNA.  Although binding is cooperative, there are no 
direct protein–protein contacts between the domains (32, 77).  The IRF3 DNA-binding 
domain contains a trihelical bundle (α1–α3) connected through three long loops (L1–L3) 
to a four-stranded antiparallel β-sheet. The recognition site is bipartite with the 3’ PRDIII 
half-site (5’-AANNGAAA-3’) being recognized by helix α3 in the major groove and the 
5’ PRDIII half-site (5’-AANNGAAA-3’) by loop L1 in the minor groove. As the two 
binding sites overlap, the 3’ PRDIII half-site has minor groove contacts through loop L1 
that extend into the binding site of the 5’ PRDIII half-site. In this configuration of the two 
binding sites, the DNA curvature stabilized by binding of one IRF-3 molecule is about 
optimal for binding of the other, explaining the cooperative binding behavior (32, 77).  
Since PRDIV and PRDIII also overlap, the 5’ IRF3 molecule has similar minor groove 
interactions that extend into the 3’ PRDIV half-site.  The simultaneous interaction of the 
3’ heterodimer subunit with the major groove and the 5’ IRF3 molecule with the minor 
groove has been proposed to induce a DNA conformation that mutually increases the 
affinities of ATF2-Jun and IRF3, thereby underlying cooperative DNA-binding (77).   
 DNase I footprinting analyses have suggested that two HMGI sites flank the 
PRDIV (nucleotides − 105 to − 98, and nucleotides − 91 to − 83) (105, 106).    Since 
HMGI failed to co-crystalize with other components of the interferon-β enhancer, the 
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stoicheometry of HMGI binding to these sites in the functional enhanceosome is not 
known.  In the absence of other proteins, however, a single molecule of HMGI has been 
proposed to utilize two of three DNA-binding domain modules to simultaneously 
recognize two sites that flank PRDIV (105).  It has been proposed that ATF2-Jun and 
IRF3 sterically exclude the binding of individual HMGI molecules to each of these sites 
(77).  However, it is possible that alternative HMGI-DNA interactions can exist in the 
presence of ATF2, Jun, and IRF3.    
 
III.B.  Heterodimer-IRF3 interactions 
 
 Virus-inducibility of reporter plasmids is strongly dependent on the helical 
phasing between PRDIV and PRDIII in reporter gene constructs (100), indicating that 
direct interactions between ATF2-Jun and IRF3 may contribute transcriptional activation.  
Since interactions with IRF3 could potentially influence the preferred orientation of 
DNA-binding by ATF2-Jun, Falvo et al. used UV-light-crosslinking to address this idea 
(34).  Whereas ATF2-Jun alone had no detectable orientation preference, co-incubation 
with IRF3 was sufficient to fix the orientation of ATF2-Jun at PRDIV such that ATF2 
favors the nonconsensus half-site (34).  Since this effect was dependent on an intact IRF3 
binding site (34), it was proposed that cooperative DNA-binding interactions between 
ATF2-Jun and IRF3 at PRDIV-III had a dominant effect on the orientation of ATF2-Jun 
binding.            
 In a subsequent study, Panne et al co-crystallized the minimal DNA-binding 
domains of ATF2, Jun, and IRF3 at PRDIV–PRDIII composite recognition element in an 
effort to explore the molecular details underlying cooperative DNA-binding interactions 
between ATF2-Jun and IRF3 (77).   In the structural model, Jun rather than ATF2 is 
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bound to the PRDIV half-site proximal to IRF3.  Based on the structure, it was apparent 
that the nucleotide used to derivatize the oligonucleotide with a photoactivatable group in 
the earlier UV-light-crosslinking experiments (34) is contacted by IRF3 rather than ATF2 
or Jun.  Therefore, the crystal structure was interpreted to more accurately reflect the 
configuration of ATF2-Jun-IRF3 complexes at PRDIV-III. 
 Despite the fixed orientation of ATF2-Jun at PRDIV in the crystal with IRF3, the 
structure reveals surprisingly few protein-protein interactions between ATF2-Jun and 
IRF3.   The only direct contact observed is between D45 of IRF3 (bound to 5’ PRDIII 
half-site) and R345 of ATF2 (bound to the PRDIV half-site).  R345A substitution in 
ATF2, however, had no detectable effect on complex formation with IRF3 at PRDIV-III 
as reveal by gel-shift analysis (77).  Since Jun does not bind tightly to 3’ nonconsensus 
PRDIV half-site and IRF3 bends the DNA toward itself and away from Jun, the authors 
attributed cooperative DNA-binding to complementary DNA conformations induced by 
the binding of ATF2-Jun and IRF3.  In support of this model, ATF2-Jun-IRF3 complex 
formation at PRDIV-III was prevented when the wild-type PRDIV site was replaced with 
the canonical CRE site at which the more optimal heterodimer-DNA contact interface in 
the 3’ half-site is predicted to preclude the DNA conformation required for IRF3 binding 
(77).   This effect, however, can also be attributed to changes in sequence rather than the 
structure of the binding site as IRF3 was shown to make specific base interactions with 
the 3’ PRDIV half-site.   
 In order to address the issue of cooperativity between ATF2-Jun and IRF3 at 
PRDIV, Dragan et al used isothermal titration calorimetry to measure the effect of ATF2-
Jun on the binding of IRF3 to PRDIV (26).  ATF2 and Jun did not noticeably affect the 
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association constant of a phosphomimetic IRF3 dimer to PRDIV-III (26).  From this, the 
authors concluded that IRF3 and ATF2-Jun do not cooperate at PRDIV-III.   Differences 
between the phosphomimetic IRF3 dimer and the minimal IRF3 DNA-binding domains 
may contribute to this lack of cooperativity as the phosphomimetic IRF3 dimer was 
shown to bind more distal to the ATF2-Jun heterodimer compared to the binding of the 
minimal DNA binding domains of IRF3 (26, 32).  However, post-translational 
modifications of IRF3 or heterodimerization with IRF7 could potentially influence 
interactions between PRDIII and the DNA-binding domain of IRF3.  Further experiments 
are needed to more clearly understand if and how the binding of IRF3 and ATF2-Jun 
cooperate at the interferon-β enhancer. 
 
III.C.  Interactions with HMGI 
 
 Past studies have produced discordant results concerning interactions among 
ATF2-Jun and HMGI at the interferon-β enhancer.  Early gel-shift analyses have shown 
that HMGI and ATF2 bind cooperatively to the PRDIV recognition element, which is 
mediated by specific protein-protein interactions between HMGI and ATF2 as a naturally 
occurring splice variant of ATF2 failed to interact with HMGI (28).  In contrast, using a 
series of HMGI protein fragments, Yie et al. demonstrated that optimal enhancement of 
ATF2-Jun binding to PRDIV correlated with the ability of HMGI to bind via 
intramolecular cooperative interactions to the enhancer and not with its ability of HMGI 
to interact with ATF2-Jun (106).  In studies describing the role of HMGI in the assembly 
of interferon-β enhanceosome in cells, Munshi et al. demonstrated that the recruitment of 
the full complement of proteins to the enhancer correlated with lysine 71-acetylation of 
HMGI by PCAF, whereas the disassembly of the complex from the enhancer correlated 
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with lysine 65-acetylation by CBP.  Furthermore, lysine 71-acetylation of HMGI 
facilitated GST-pull-down of the enhancer proteins by HMGI and protected the 
enhanceosome from disruption in vitro by inhibiting CBP-induced acetylation at K65 
(71).  However, studies of the interferon-β enhancer region in vitro analyses do not 
mention HMGI either as a component of the complex or as a means responsible for the 
cooperation of the other components (26, 76, 77).   
 In order to address the role of HMGI in cooperativity among ATF2-Jun and IRF3 
at PRDIV, Dragan et al. used isothermal titration calorimetry to measure the effect of 
HMGI on stabilization of ATF2-Jun-IRF3 complex formation at PRDIV (26).  HMGI did 
not affect the association constant of ATF2-Jun and a phosphomimetic IRF3 dimer to 
PRDIV-III (26).  Likewise, IRF3 did not affect the association constant of ATF2-Jun and 
HMGI to PRDIV-III (26).  From this, the authors concluded that IRF3 and HMGI 
compete for interactions with the DNA.  However, due the indirect nature of these 
experiments, it is not possible to determine whether competition between HMGI and 
ATF2-Jun for DNA (in the former experiment) or between IRF3 and ATF2-Jun for DNA 
(in the later experiment) rather than between IRF3 and HMGI for DNA was occurring.  
Furthermore, even if such competition does occur, post-translational modifications of 
HMGI may influence its interactions with ATF2, Jun, and IRF3 at the interferon-β 
enhancer as suggested by Munshi and colleagues (71).  Therefore, the molecular details 
underlying ATF2, Jun, IRF3, and HMGI interactions at the interferon-β enhancer remains 
an outstanding problem.  
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IV.  STATEMENT OF THE PROBLEM 
 
 
 My thesis work is predicated on the assumption that understanding the structural 
basis for the formation of different configurations of the single transcription factor 
complex will provide a valuable model system for determining the role of nucleoprotein 
architecture in gene transcription.  ATF2-Jun-IRF3 represents a transcription factor 
complex for which alternative structural configurations have been proposed at the same 
DNA sequence (26).   The atomic resolution structure of minimal DNA-binding domains 
of ATF2, Jun, and IRF3 bound to the interferon-β enhancer element was previously 
completed to identify the amino acid residues at the interaction interface of ATF2-Jun 
heterodimers and IRF3 (77).   However, efforts towards characterization of the roles of 
these and other residues in ATF2-Jun-IRF3 complex formation have proved difficult. 
Thus, the interactions governing the configuration(s) of this complex remain unknown.  
 This thesis presents both structural and functional characterization of ATF2-Jun-
IRF3 complexes at the interferon-β enhancer.  To that end, the techniques of gel-based 
fluorescence resonance energy transfer (gelFRET), quantitative gel-shift, and quantitative 
real-time PCR analyses were utilized to describe how symmetry-related amino acid 
residues in ATF2 and Jun influence interactions with IRF3, the orientation of DNA-
binding by ATF2-Jun, and interferon-β gene transcription.   Co-expression of IRF3 
together with ATF2-Jun heterodimer variants which bind to DNA in opposite orientations 
in vitro had distinct effects on the efficiency of endogenous interferon-β gene expression 
in Sendai virus-infected cells and this correlated with different relative efficiencies of 
bATF2-bJun-iIRF3 complex formation at the interferon-β enhancer element in vitro.  
Consistent with a role for cooperative DNA-binding interactions among ATF2, Jun, and 
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IRF3 in interferon-β activation, we observed that the DNA-binding domains of ATF2 and 
Jun mediated the effects of heterodimer orientation on interferon-β transcription, whereas 
the activation domains mediated the effect of heterodimer orientation at genes not 
regulated by composite ATF2-Jun-IRF3 sites.  Further, this work highlights a role for 
synergistic effects of iIRF3 and HMGI on the stabilization of alternative bATF2-bJun 
binding orientations in vitro.  Collectively, these results indicate that alternative 
interactions between ATF2-Jun and IRF3 permit opposite orientations of heterodimer 
binding at the interferon-β enhancer, with distinct effects on the stability of complex 
formation in vitro and on endogenous gene expression in vivo.     
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CHAPTER 2:  ORIENTATION PREFERENCE OF bATF2-bJUN IN AN 
INTERFERON-β ENHANCER COMPLEX 
 
 
 
I.  INTRODUCTION 
 
 
 
I.A.  Principle of gelFRET 
 
 
 
 In efforts to understand the structural determinants of oriented DNA-binding by 
bZIP heterodimers, Diebold and Kerppola developed a novel gel-based fluorescence 
resonance energy transfer (gelFRET) assay (4, 9).  Conventional FRET approaches lend 
several obstacles in studies of nucleoprotein architecture, including interference from 
unbound protein and DNA during FRET detection and uncertainty in absolute distance 
measurements.  A specific advantage of gelFRET analysis in the analysis of heterodimer-
DNA complexes is that the different mobilities of complexes formed by ATF2-Jun 
heterodimers, Jun homodimers, and ATF2 homodimers during gel electrophoresis allow 
separation and analysis of the individual complexes. The structural organization of 
heterodimer-DNA complexes are investigated through comparison of the relative 
efficiencies of energy transfer from donor fluorophores linked to different positions on 
DNA to an acceptor fluorophore linked to a unique position on the heterodimer.  This 
provides a quantitative measure of the orientation preference of heterodimer binding 
without the need to establish the absolute distances between fluorophores.    
 46
I.B.  Determination of heterodimer orientation preference 
 
 
 Analysis of DNA-binding orientation of bZIP heterodimer complexes by 
gelFRET requires comparison of the relative efficiencies of energy transfer from a donor 
fluorophore linked to either end of a double-stranded DNA oligonucleotide to an acceptor 
fluorophores linked to one subunit of the heterodimer. Complexes in which the donor and 
acceptor fluorophores are closer together are predicted to exhibit higher efficiencies of 
energy transfer than complexes in which the donor and acceptor fluorophores are far 
apart.  If placement of the acceptor fluorophore on the opposing heterodimer subunit 
enhances energy transfer from one end of the DNA while reducing energy transfer from 
the other end of the DNA [Fig 2.1A], we interpret the relative efficiencies of energy 
transfer from opposite ends of the DNA to be related to the preferred orientation of 
heterodimer binding.   
 Since the gelFRET assay for heterodimer orientation does not require absolute 
distance measurements, an acceptor-to-donor emissions ratio is used instead of the more 
traditional efficiency of energy transfer.  The acceptor-to-donor ratio is a function of the 
efficiency of energy transfer and provides a convenient measure for comparison of 
energy transfer between fluorophore pairs placed at different positions in a complex. 
Since we are concerned with comparison of energy transfer from opposite ends of the 
oligonucleotide, the acceptor-to-donor ratio provides the same information regarding the 
relative abilities of fluorophores on opposite ends of the oligonucleotide to donate energy 
to the acceptor. The end preference (EP) is calculated based on the acceptor-to-donor 
ratios in complexes labeled on the left versus the right ends. 
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 For a population of heterodimers containing complexes bound in both orientations, 
end preference reflects the average between the efficiencies of energy transfer for 
complexes bound in opposite orientations weighted by the fraction of complexes bound 
in each orientation.  Differences in the end preference values of heterodimers labeled on 
the same subunit are therefore proportional to differences in the fraction of heterodimers 
bound in each orientation.  For a perfectly symmetric complex, the sum of the end 
preference values is predicted to equal 1.  If the complex is unoriented, heterodimer-DNA 
complexes are predicted to exhibit similar energy transfer from opposite ends of each 
oligonucleotide, and thus their end preference values should be equal to 0.5.  However, 
for most complexes, the sum of end preference values is not exactly equal to 1 and, when 
similar, the end preference values were not always equal to 0.5. These deviations from 
perfect symmetry do not interfere with determination of the relative orientation 
preferences of different complexes based on differences in the end preference values of 
heterodimers labeled on different subunits. However, determination of the fraction of 
heterodimers bound in each orientation requires additional information.  
 
I.B.i.  Calibration with oriented heterodimers 
 
 
 To establish the relationship between the end preference values and the fraction of 
ATF2-Jun heterodimers bound in each orientation, we have used calibration standards to 
determine the end preference values of fully oriented ATF2-Jun complexes. Comparison 
of the end preference values of ATF2-Jun heterodimers with those of fully oriented 
complexes allows for quantification of the absolute fraction of heterodimers bound in 
each orientation.  We developed a calibration strategy by taking advantage of the 
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influence of the central asymmetric base pair in the AP-1 site on the orientation of Fos–
Jun binding.  Fos-Jun heterodimers that bind the AP-1 site in opposite orientations 
contact the central guanine of the AP-1 site using arginine residues from different 
subunits (7, 10).  Our strategy is based on the use of ATF2–Jun heterodimers in which the 
analogous arginine in either ATF2 or Jun that can contact the central guanine in the 
interferon-β ATF/Jun site is replaced in either subunit by alanine.  Replacement of the 
arginine residue that contacts the central asymmetric guanine in different subunits 
(bATF2XG–bJun vs bATF2–bJunXG) is predicted to shift the orientation of heterodimer 
binding in opposite directions (Fig  2.1B).  To determine the fraction of complexes bound 
in each orientation (ATF2-Jun and Jun-ATF2), we use these standards to calibrate the 
relationship between end preference and heterodimer binding orientation. Calibration of 
the gelFRET assay allows us to estimate the end preference values of fully oriented 
complexes and thus enables calculation of the fraction of complexes bound in each 
orientation.  
  
II.  RESULTS AND DISCUSSION 
 
 
II.A.  Orientation preference of bATF2-bJun at IFNb 
 
 
 To establish whether ATF2-Jun heterodimers bind the interferon-β enhancer in 
one or both orientations, heterodimers were formed using truncated ATF2 and Jun 
encompassing the bZIP dimerization and DNA-binding domains and 14 residues on the 
amino-terminal sides of the basic regions [bATF2 and bJun, Fig. 2.6B].  Either bATF2 or  
 49
ATF2•Jun
Free DNA
Jun
ATF2
RL RL RL RL RL RL RL RL
bATF2 bATF2 bATF2 bATF2 bATF2 bATF2 bATF2bJUN
bJUN bJUN bJUN bJUN bJUN bJUN bJUNbATF2
XG XG
XG XG
ATF2•Jun•IRF3
Free DNA
ATF2•IRF3
Jun•IRF3
RL RL RL RL RL RL RL RL
iIRF3
bATF2 bATF2 bATF2 bATF2 bATF2 bATF2 bATF2bJUN
bJUN bJUN bJUN bJUN bJUN bJUN bJUNbATF2
XG XG
XG XG
iIRF3
HMGI
Free DNA
IRF3•HMGI
HMGI
Jun•IRF3•HMGI
ATF2•IRF3•HMGI
RL RL RL RL RL RL RL RL
bATF2 bATF2 bATF2 bATF2 bATF2 bATF2 bATF2bJUN
bJUN bJUN bJUN bJUN bJUN bJUN bJUNbATF2
XG XG
XG XG
En
d 
Pr
ef
e r
en
ce
L
R
bATF2
bJUN
bATF2
bJUN
XG
bATF2
bJUN
XG(b
AT
F2
) 2
(b
JU
N)
2
GRAGRR GRAGR R
En
d 
Pr
ef
e r
en
ce
L
R
iIRF3
bATF2
bJUN
bATF2
bJUN
XG
bATF2
bJUN
XG(b
AT
F2
) 2
(b
JU
N)
2
GRAGRR GRA
GR R
L
R
En
d 
Pr
ef
er
en
ce
bATF2
bJUN
bATF2
bJUN
XG
bATF2
bJUN
XG(b
AT
F2
) 2
(b
JU
N)
2
iIRF3
HMGI
GRR GR A GRA
GR R
0.25
0.35
0.45
0.55
0.65
0.75
0.35
0.45
0.55
0.65
0.75
0.85
0.3
0.4
0.5
0.6
0.7
0.8
GR R
GR R
GR R
C
D
E
ATF2•Jun•IRF3•HMGI
RL
bATF2•bJun
RL
bATF2•bJun
R270
G21′
bATF2 bJun
R352GR A GR A
A B
 
Fig. 2.1. bATF2-bJun heterodimers bind IFNb in both orientations in association with iIRF3 and 
HMGI. (A) Diagram illustrating the determination of bATF2-bJun heterodimer orientation at IFNb by 
gelFRET analysis.  bATF2(orange)-bJun(cyan) heterodimers labeled with TR (red) on either subunit were 
bound to IFNb (yellow) labeled with 6-FAM (green) at either the left (L) or the right (R) end.  bATF2-bJun 
heterodimers that bind to IFNb in opposite orientations are predicted to produce different  relative 
efficiencies of energy transfer from donor fluorophores linked to opposite ends of the oligonucleotide.  (B) 
Molecular model depicting symmetry-related arginines in the basic regions of ATF2 (R352) and Jun 
(R270), only one of which can contact the asymmetric guanine (G21’) in IFNb depending on the 
orientation of heterodimer binding.  The model was created using PyMOL Molecular Graphics System (3) 
and coordinates from the RCSB Protein Data Bank [www.pdb.org (1), PDB ID: 1T2K] in agreement with 
the published structure (12).  The diagrams to the left and right of the structure show the predicted shifts in 
heterodimer orientation resulting from substitution of the arginine in either subunit by an alanine.  (C) 
GelFRET analysis of the orientation of bATF2-bJun binding at IFNb.  The proteins labeled with TR are 
shown in red type above the lanes.  The oligonucleotide ends labeled with 6-FAM are shown below the 
lanes.  The diagrams below the bar graphs indicate the preferred orientations of dimer binding. (D) 
GelFRET analysis of complexes formed by the same proteins in association with iIRF3 (green oval). (E) 
GelFRET analysis of complexes formed by the same proteins in association with iIRF3 and HMGI (blue 
oval).  The data shown represent the mean values and standard deviations from at least two separate 
experiments. 
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bJun was labeled with Texas red C5-bromoacetamide (TR) on a cysteine residue at the 
amino-terminal end [Fig 2.6B].  The heterodimers were incubated with DNA duplexes 
centered on the ATF2-Jun recognition sequence in the promoter-proximal interferon-beta 
enhancer element [IFNb, Fig. 2.6A]. IFNb was labeled at the 5’ end of either the sense 
(left end) or the anti-sense (right end) strand with 6-carboxyfluorescein (6-FAM) [Fig. 
2.6A].  bATF2-bJun-IFNb complexes were separated by polyacrylamide gel 
electrophoresis and were analyzed by scanning the gel using a laser that preferentially 
excited the donor fluorophore.  The fluorescence emissions of both donor (green) and 
acceptor (red) fluorophores were measured at each position of the gel and were 
superimposed to produce the figure.  Complexes formed by bATF2-bJun heterodimers 
migrated with mobilities distinct from complexes formed by either bATF2 or bJun 
homodimers [Fig. 2.1C].        
 We measured the relative efficiencies of energy transfer from the left versus right 
ends of IFNb by comparing the acceptor-to-donor emissions ratios of bATF2-bJun-IFNb 
complexes labeled on the left versus the right end of IFNb.  The relative end preferences 
of complexes labeled on bATF2 (orange bars) versus bJun (cyan bars) were used to 
determine the preferred orientation of heterodimer binding at IFNb.  We used labeled 
bATF2 and bJun homodimers to estimate the end preferences of complexes that had no 
orientation preference.  Homodimers formed by labeled bATF2 or by labeled bJun had 
similar end preference values.  In contrast, heterodimers labeled on bATF2 had a higher 
(left) end preference than heterodimers labeled on bJun [Fig 2.1C].  This indicates that 
bATF2-bJun bound IFNb in a preferred orientation in which bATF2 favored the left half-
site and bJun favored the right half-site.   
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II.A.i.  Effect of XG-substitutions in bATF2 versus bJun 
 
 The difference in end preferences between bATF2-bJun heterodimers labeled on 
bATF2 versus bJun indicated that the heterodimer binds to IFNb in a preferred 
orientation.  However, this does not indicate the heterodimer binds in only one 
orientation. To estimate the degree of orientation preference of bATF2-bJun at IFNb, we 
compared the end preferences of wild-type heterodimers with those of heterodimers 
containing amino acid substitutions that are predicted to bias the orientation of 
heterodimer binding.   Previous studies have shown that mutually exclusive interactions 
between the central asymmetric guanine base in the AP-1 recognition sequence and 
symmetry-related arginine residues in Fos versus Jun mediate opposite orientations of 
Fos-Jun heterodimer binding (7, 10).  The homologous arginine residue in ATF2 (R352) 
contacts the central asymmetric guanine base (G21’) in the crystal structure of DNA-
binding domains of ATF2, Jun, and IRF3 bound to the interferon-β enhancer (12). We 
predicted that alternative interactions between R352 of bATF2 or the homologous 
arginine in bJun (R270) with the asymmetric guanine base could similarly mediate 
opposite orientations of bATF2-bJun binding to IFNb.  
 Substitution of R352 in bATF2 by an alanine (bATF2XG) reversed the relative 
end preferences of heterodimers labeled on bATF2 versus bJun compared to the wild 
type proteins.  Conversely, substitution of the homologous arginine (R270) in bJun by an 
alanine (bJunXG) increased the difference between the end preferences of heterodimers 
labeled on bATF2 versus those labeled on bJun compared to the wild type proteins.  
These results are consistent with reversal of the orientation of bATF2-bJun binding by 
the former substitution and enhancement of the orientation preference by the latter 
 52
substitution  [Fig 2.1C]. The effects of these amino acid substitutions were reversed by 
inversion of the asymmetric central base pair, and these substitutions had no detectable 
effect on end preferences at a binding site containing a symmetrical central dinucleotide 
(data not shown). Amino acid substitutions at either R352 of bATF2 or R270 in bJun can 
therefore control the orientation of bATF2-bJun heterodimer binding at IFNb by altering 
contacts with the asymmetric central guanine.    
To determine the proportion of bATF2-bJun heterodimers that bound IFNb in 
each orientation, we compared the end preferences of wild type bATF2-bJun 
heterodimers and those of heterodimers containing either the R352A or R270A 
substitutions.  The larger differences in the end preferences of bATF2XG-bJun and 
bATF2-bJunXG heterodimers labeled on different subunits compared to those of wild-
type heterodimers indicate that although wild type bATF2-bJun heterodimers bind IFNb 
in a preferred orientation, they do not bind IFNb in a fixed orientation.  We estimate that 
no more than 70% of bATF2-bJun heterodimers bind IFNb in the orientation where Jun 
favors the right half-site.  
 
II.B.  Analysis of bATF2-bJun-iIRF3-IFNB complexes 
 
 
 Two IRF3 molecules can bind to sites overlapping and downstream of the ATF2-
Jun recognition sequence in IFNb [Fig. 2.1A].  We examined the effect of truncated IRF3 
encompassing the minimal DNA binding domain (iIRF3: residues 1 to 111) on the 
orientation preference of bATF2-bJun binding at IFNb.  iIRF3 alone did not form a stable 
complex at IFNb, but its binding was stabilized by association with bATF2-bJun [Fig. 2.2, 
compare lanes 2 and 4].  iIRF3 binding was also stabilized by association with bATF2 
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and bJun homodimers as well as with bATF2XG-bJun and bATF2-bJunXG heterodimers 
[Fig. 2.1D]. iIRF3 binding can therefore be stabilized by multiple configurations of 
bATF2 and bJun heterodimers and homodimers. 
 
 
ATF2•JUN
ATF2•JUN•(IRF3)2
Free DNA
ATF2•JUN•IRF3•(HMGI)n
(IRF3)2 / (HMGI)4n / (IRF3)2•(HMGI)2n
(HMGI)6n / (HMGI)3n•(IRF3)3
(HMGI)8n / (HMGI)4n•(IRF3)4n
* *
iIR
F3
bA
TF
2,
bJ
U
N
bA
TF
2,
bJ
U
N
,iI
R
F3
HMGI
HMGI HMGI HMGI
bATF2,bJUN,iIRF3bATF2,bJUNiIRF3
(HMGI)2n / (HMGI)n•IRF3
*
 
 
Fig. 2.2.  HMGI co-binds with bATF2-bJun-iIRF3 complexes at IFNb. (The proteins indicated above 
the lanes were incubated with IFNb, and the complexes were separated by gel electrophoresis.  Formation 
of multi-subunit complexes was inferred based on comparison of the banding patterns in lanes with 
multiple proteins versus lanes containing the individual protein or pair-wise combinations of proteins.   
 
 
 iIRF3 binding increased the efficiencies of energy transfer from the left compared 
to the right end of IFNb for all complexes, resulting in higher absolute end preference 
values for all heterodimers and homodimers [compare Fig. 2.1C and 2.1D].  However, 
iIRF3 binding did not change the relative end preferences of heterodimers labeled on 
bATF2 versus bJun compared with those of bATF2 and bJun homodimers. The changes 
in the absolute, but not in the relative end preference values of these complexes upon 
iIRF3 binding were likely caused by changes in the structures of these complexes that 
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altered the relative efficiencies of energy transfer from opposite ends of the 
oligonucleotide, but did not change heterodimer orientation. Taken together, the absence 
of a change in bATF2-bJun orientation preference upon iIRF3 binding and the 
stabilization of iIRF3 binding by bATF2 homodimers, bJun homodimers, and bATF2-
bJun heterodimers bound in opposite orientations suggest that iIRF3 can interact equally 
with bATF2 and with bJun at IFNb.   
 
 
II.C. Analysis of bATF2-bJun-iIRF3-HMGI complexes 
 
 
 
 The structural nature and specificity of HMGI interactions with ATF2-Jun-IRF3 
and the interferon-β enhancer remain unclear.  Studies have suggested that one HMGI 
molecules bind to at least two sets of AT-rich sequences that flank PRDIV (14).  
However, attempts to co-crystalize HMGI with ATF2, Jun, and IRF3 at an interferon-β 
enhancer elements have failed (12).  Furthermore, studies by Dragan et al. have 
suggested that HMGI and IRF3 compete for binding to the interferon-β enhancer in the 
presence of ATF2-Jun heterodimers (5). 
 
II.C.i.  Gel-shift analysis of HMGI complexes 
 
 We investigated the effects of HMGI binding on the mobility of bATF2-bJun-
iIRF3 complexes at IFNb.   HMGI alone formed at least four complexes with different 
electrophoretic mobilities at IFNb [Fig. 2.2, 2.3].  The addition of HMGI to bATF2-bJun 
produced a complex with mobility distinct from either HMGI or bATF2-bJun alone [Fig. 
2.2], indicating the formation of a bATF2-bJun-HMGI complex at IFNb. The addition of 
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Fig. 2.3. Formation of HMGI-IRF3 heterodimers at IFNb. The proteins indicated above the lanes were 
incubated with IFNb, and the complexes were separated by gel electrophoresis.  To determine whether 
HMGI and iIRF3 form a complex at IFNb, the banding pattern for SUMO-HMGI fusion protein (sHMGI) 
together with iIRF3 was compared to the banding pattern for each protein alone.  The addition of HMGI to 
lanes containing iIRF3 eliminated the smearing seen in lanes containing iIRF3 alone yet resulted in bands 
whose mobilities were indistinguishable from lanes containing HMGI alone.   
 
 
   
HMGI to iIRF3 produced the same mobility complexes observed for HMGI alone while 
eliminating the smearing observed in the presence of iIRF3 alone, indicating that HMGI 
either competitively inhibits the binding of iIRF3 or that iIRF3 is contained in the bands 
observed [Fig.  2.2].        
 To distinguish between complexes containing either HMGI alone or HMGI and 
iIRF3 together, the bands formed by IFNb were compared in the presence of SUMO-
tagged HMGI (SUMO-HMGI), iIRF3, or SUMO-HMGI and iIRF3 together.   SUMO-
HMGI and iIRF3 in combination formed complexes that were not observed in the 
presence of either protein alone [Fig. 2.3], indicating that SUMO-HMGI and iIRF3 
formed a complex at IFNb.  Gradual increases in HMGI concentration to either bATF2-
bJun or bATF2-bJun and iIRF3 together produced a complex with mobility 
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corresponding to HMGI alone at the expense of either bATF2-bJun-HMGI or bATF2-
bJun-iIRF3-HMGI complexes, suggesting that HMGI and bATF2-bJun can compete for 
binding to IFNb [Fig. 2.2].   
 
II.C.ii.  Effect of HMGI on heterodimer orientation  
  
 To determine the orientation preference of bATF2-bJun in the presence of HMGI 
and iIRF3, the relative end preference values for bATF2-bJun-iIRF3-HMGI complexes 
labeled on bATF2 versus bJun were compared to the relative end preference values of 
complexes containing bATF2 homodimers, bJun homodimers, bATF2XG-bJun 
heterodimers, or bATF2-bJunXG heterodimers bound to IFNb.  Similar to the analysis of 
homodimers alone and homodimers in the presence of iIRF3, bATF2 and bJun 
homodimers in combination with iIRF3 and HMGI had end preference values that were 
not significantly different from each other [Fig. 2.1E].  Also, even in the presence of 
HMGI, bATF2XG-bJun and bATF2-bJunXG had strong, opposite orientation preferences 
[Fig. 2.1E].           
 In contrast, HMGI binding caused a shift in the relative end preferences of wild-
type bATF2-bJun heterodimers in association with iIRF3 [Fig. 2.1E].  Whereas bATF2 
favored binding to the left half-site and bJun to the right half-site alone and in the 
presence of iIRF3, the difference in the end preference values of bATF2-bJun 
heterodimers labeled on different subunits was markedly reduced upon HMGI binding to 
complexes containing iIRF3 at IFNb [compare Fig. 2.1D and 2.1E].  In contrast, HMGI 
binding had little effect on the relative end preference values of bATF2XG-bJun and 
bATF2-bJunXG heterodimers [compare Fig. 2.1D and 2.1E].  Thus XG amino acid 
substitutions inhibit the effect of HMGI on heterodimer orientation preference, indicating 
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that the effects of HMGI on the orientation preference of wild-type heterodimers are 
mediated through interactions between bATF2-bJun and DNA.  
 
II.D.  Comparison of different fluorophores and oligonucleotides 
 
 
 Labeling of the protein and DNA with fluorescent probes could alter their 
functional properties by inducing alternative conformations or steric hindrance.  We 
investigated potential effects of the fluorophore used to label bATF2 and bJun on 
gelFRET analysis of the orientation of bATF2-bJun binding in complexes with iIRF3 and 
HMGI [Fig. 2.4].  There was no detectable difference in the effects observed when 
bATF2-bJun heterodimers labeled with Alexa568 (AX) [Fig. 2.4] compared to 
heterodimers labeled with Texas red C5-bromoacetamide (TR).  Thus, the fluorescent 
label did not influence the fraction of heterodimers bound in each orientation.  Similarly, 
DNA oligonucleotides 47 bp in length (IFN47) resulted in equivalent orientation 
preferences obtained after calibration of the end preference values [Fig. 2.4]. Thus, the 
fluorescent labels did not influence the orientation of bATF2-b-Jun heterodimer binding. 
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Fig. 2.4.  The effects iIRF3 and HMGI on bATF2-bJun orientation preference are comparable in 
complexes that are conjugated to a different acceptor label and that include a larger oligonucleotide. 
(A) Gel separated of Alexa568 (AX)-labeled (bATF2)2, (bJun)2, and bATF2-bJun complexes bound to a 
47-bp oligonucleotide (IFN47).  (B) Relative end preferences of complexes labeled on different subunits. 
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II.E.  Effects of regions outside of bATF2 and bJun 
 
 
 To test potential effects of regions missing in bATF2 and bJun, we measured the 
effects of iIRF3 and HMGI on the end preferences of heterodimers formed by full-length 
ATF2 with labeled bJun and labeled bATF2 with full-length Jun.  iIRF3 binding to IFNb 
had little effect on the relative end preferences of these heterodimers, consistent with the 
lack of an effect of iIRF3 on the orientation of bATF2-bJun heterodimers [Fig. 2.5].  
Moreover, the relative end preferences of heterodimers formed by full-length ATF2 with 
labeled bJun and labeled bATF2 with full-length Jun in association with iIRF3 were 
reduced upon HMGI binding to IFNb [Fig 2.5].  Thus, iIRF3 as well as HMGI had 
similar effects on the orientations of bATF2-bJun heterodimers and on heterodimers 
formed by the full-length protein with bATF2 and with bJun. bATF2 and bJun are 
therefore valid models for studies of interactions with iIRF3 and HMGI.   
 
III.  SUMMARY AND CONCLUSIONS 
 
 
 Previous studies regarding the mechanism of cooperative DNA-binding by ATF2-
Jun and IRF3 at the interferon-β enhancer element have produced discordant results (6, 
12).  We believe that our assay more accurately reveals the true nature of this regulatory 
complex than past methods because the photo-crosslinking method assay was designed in 
the absence of a detailed structural understanding of the complex, whereas bATF2, bJun, 
and IFNb labels used in my analysis were placed at safe distances from the heterodimer-
IRF3 interaction surfaces that have been revealed by x-ray crystallography (12).   
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Fig. 2.5.  Domains outside of either bATF2 or bJun do not qualitatively influence the relative end 
preferences of bATF2-bJun, bATF2-bJun-iIRF3, or bATF2-bJun-iIRF3-HMGI complexes at IFNb. 
The end preferences of heterodimers containing one labeled truncated subunit and one full-length subunit 
(ATF2-bJunTR versus ATF2TR-Jun) were determined at the IFN40 site alone, with bound iIRF3, or with 
bound iIRF3 and HMGI.  Similar to complexes containing two truncated subunits, the end preference value 
for Jun-labeled subunits was significantly higher than the end preference value for ATF2-labeled 
complexes in either the absence or presence of iIRF3.  Also similar to complexes containing two truncated 
subunits, the end preference value for Jun-labeled subunits was more similar to the end preference value for 
ATF2-labeled complexes in the presence of HMGI.  Together, this indicated that domains not included in 
bATF2 or bJun do not interact with iIRF3 or iIRF3 and HMGI together. 
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Furthermore, although the crystal structure can accurately reflect specific protein-protein 
and protein-DNA contacts that occur, it can at the same time, impose artificial order 
restrictions on intrinsic disorder within the complex such as an opposite binding 
orientation that occurs in a minority of complexes.  Similar interpretations have been 
made for incongruous results for x-ray crystallographic and solution studies of the DNA-
binding orientation preference of TATA-binding protein (2). 
 My orientation preference results are supported by recent microcalorimetry 
analysis that indicate 70% of ATF2-Jun-DNA complexes have a heterodimer orientation 
in which Jun is bound to the right half-site and that this orientation preference does not 
change with the addition of IRF3 (5, 8).  My study, however, contradicts their data that 
indicates IRF3 and ATF2-Jun bind independently. We clearly show that specific amino 
acid mutations in ATF2, Jun, and IRF3 can functionally interact in the context of 
heterodimer binding orientation preference and IRF3 binding.  Although these 
interactions do not significantly affect the amount of ATF2-Jun binding, they do 
significantly affect IRF3 binding.  It appears that cooperative binding with IRF3 in some 
way inhibits the interaction of ATF2-Jun with its binding site such that the effect of 
favorable interactions with ATF2-Jun on ATF2-Jun binding is cancelled out.   This 
observation is supported by the x-ray crystal structure where the binding of the 5’ IRF3 
molecule appears to bend the DNA away from the heterodimer subunit that binds the 
right half-site.    
 Recent publications do not mention HMGI as a component of the enhanceosome 
or as a means responsible for the cooperation of its components (5, 11, 12).  Exclusion of 
HMGI from considerations of enhanceosome assembly was perhaps a consequence of 
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failure to co-crystallize HMGI and other components of the complex previously thought 
to interact with HMGI (12).    Furthermore, in a recent study, similar fluorescence 
anisotropy binding isotherms for IRF3 titrated against either the interferon-β enhancer 
element or ATF2-Jun-HMGI-DNA complexes have indicated that HMGI does not 
contribute to cooperative DNA-binding by ATF2-Jun and IRF3 on the interferon-β 
enhancer element (5).  Furthermore, since the difference between the two binding 
isotherms was so small, they concluded that IRF3 displaces HMGI entirely from the 
DNA (5).  Thus, the role of HMGI in the assembly of the enhanceosome remains an 
outstanding problem.  We have shown that although HMGI only contributes modestly to 
ATF2-Jun-IRF3-DNA complex formation and that IRF3 may displace the 3’ HMGI 
molecule, at least one HMGI molecule indeed co-binds with ATF2-Jun and IRF3 on 
DNA where it decreases the energy barrier between two opposite ATF2-Jun binding 
orientations at the IFNβ enhancer.    This reveals the limitations of solution studies which 
may not be as sensitive to specific multi-component complexes that have multiple 
potential stoicheometries and interactions. 
 
 
IV.  MATERIALS AND METHODS 
 
 
IV.A.  Design of fluorescently-labeled complexes 
 
 
 For the analysis of the orientation preference of ATF2-Jun heterodimers within in 
vitro assembled interferon-β enhancer complexes, it was necessary to construct longer 
ATF2 and Jun proteins than the bZIP protein fragments traditionally used for gelFRET in 
order to examine the effects of these additional residues on cooperative interactions with 
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other proteins.  It was also necessary to utilize longer oligonucleotides that included 
sequences from the interferon-β enhancer which contained binding sites for other 
proteins.  These minimal adjustments allowed detection of the effect of cooperative 
interactions with other proteins on the orientation of ATF2-Jun binding while, at the same 
time, allowing FRET to occur between donor fluorophores places at either end of the 
oligonucleotide to the N-terminal residue of either ATF2 or Jun. 
 
IV.A.i.  Donor and acceptor fluorophores 
 
 Fluorescein derivatives are the most common organic dyes used for labeling 
proteins and nucleic acids. Although fluorescein derivatives bleach relatively easily, this 
is not a concern for gelFRET experiments, since the fluorophores are exposed to the 
excitation beam for a very short time (approximately 1 ms). The more stable 
carboxyfluorescein (FAM) is a convenient green fluorophore for oligonucleotide labeling. 
Fluorescein is a good donor fluorophore due to its high quantum yield and excitation 
maximum (494 nm), which allows optimal excitation by the 488-nm argon-ion laser.  
Fluorescein has an emission spectrum (maximum: 525) that overlaps with the excitation 
spectrum of the long-wavelength dye Texas Red (maximum: 582). Texas Red conjugates 
have a fluorescence emission spectrum (maximum: 600) that makes them good long-
wavelength acceptor dyes for FRET analysis with fluorescein donors. Texas Red 
conjugates have a higher quantum yield and provide a higher signal over background 
than conjugates of other long-wavelength red fluorescent dyes, such as rhodamines. In 
addition, the maleimide and bromoacetamide derivative of Texas Red enables thiol-
specific labeling of proteins. Hence fluorescein and Texas Red is a useful donor–acceptor 
pair for gelFRET analysis of nucleoprotein complexes. 
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 The R0 distances for most commonly used donor–acceptor pairs are in the range 
20–60 A°, and are therefore comparable to the distances between sites on multisubunit 
complexes and the diameters of many biomolecules. Changes in the distance between the 
fluorophores have a larger effect on FRET when the distance separating the fluorophores 
is near the R0 value for the donor–acceptor pair used. If the donor–acceptor distance 
narrows to about half the R0 value, the FRET efficiency is increased to nearly 
quantitative energy transfer; conversely, if the donor–acceptor distance increases by half 
the R0 value, the FRET efficiency is reduced to a nearly undetectable level. Given that 
the efficiency of FRET depends on the distance between the fluorophores, structural 
transitions in nucleoprotein architecture can be detected by measuring changes in the 
efficiency of energy transfer which are due to changes in the proximity of the two 
fluorophores. 
 
IV.A.ii.  Preparation of IFNb oligonucleotides 
 
 We use DNA oligonucleotides that are designed to place the donor fluorophores 
at symmetric positions on opposite sides of the PRDIV recognition element [IFNb, Fig 
2.6A]. A 5 base-pair symmetry extension (indicated by line) was appended to the 5’ end 
of the sense strand and the 3’ end of the anti-sense strand in order to ensure that the local 
environments of the donor fluorophores on opposite ends of the oligonucleotide are 
equivalent.  Oligonucleotide synthesis and conjugation of the 5’ phosphates to 6-
carboxyfluorescein was performed by Integrated DNA Technologies, Inc. (Coralville, IA) 
Duplexes were prepared by annealing 5’-labeled oligonucleotides to unlabeled strands (4 
mg/ml duplex) in the presence of 10 mM KCl by heating to 95°C for a few minutes in a  
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 Fig. 2.6. Design of donor- and acceptor-labeled bATF2-bJun-IFNb complexes. (A) Diagram illustrating 
recognition sequences in the interferon-β enhancer oligonucleotide (IFNb).  The IFNb oligonucleotide 
contained base pairs -109 to -75 of the human interferon-β element with an additional 5 base pairs 
symmetrical to the downstream end added to the upstream end (indicated by line).  The core ATF2, Jun, 
and IRF3 recognition sequences are indicated by brackets.  The approximate sequences that are contacted 
by HMGI (indicated by brackets) have been determined based on DNase I protection analysis (13, 14).  The 
5’-phosphates labeled with 6-FAM in left- and right-end labeled duplexes are indicated by arrows.  (B) 
Diagram illustrating bATF2 (amino acid residues 322-397 of human ATF2) and bJun (amino acid residues 
240-315 of human Jun) protein fragments.  bATF2 residues 353-397 and bJun residues 271-315 are not 
shown.  Amino acid residues in bATF2 and bJun that were included in the crystal structure (Panne et al. 
2004) are depicted as alpha-helices whereas residues not included in the crystal structure are depicted as 
coils.  The amino-terminal cysteine residues used for labeling with TR are indicated by red font.  Arginine 
residues in bATF2 and bJun that contact the central guanine bases of AP-1 and CRE sites are highlighted in 
yellow.   
 
water bath and then slowly reducing the temperature to 25°C. The duplexes were 
separated from single strands by 5% PAGE in 25 mM Tris, 195mM glycine gel buffer 
run for 2 h at room temperature. The labeled duplex bands were visualized using an UV 
transilluminator and excised. Subsequently, the annealed duplexes were recovered by 
overnight incubation in TE buffer at 37°C. Approximately 60% of the annealed DNA 
was recovered under these conditions. The annealed duplexes were stored in the dark at -
20°C. The concentrations of the duplexes were determined spectrophotometrically at 260 
nm. 
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IV.A.iii.  Preparation of bATF2, bJun, iIRF3, and HMGI proteins 
 
 Since the X-ray crystal structure of ATF2-Jun-IRF3 at the interferon-β enhancer 
element was available, sites for fluorophore coupling could be introduced at positions 
that are predicted not to alter biological functions such as DNA binding and interactions 
with IRF3.  The amino acid residues on the amino-terminal sides of the basic regions of 
ATF2 and Jun project down out of the major groove. These residues are shifted by 
approximately 30 Å between the two orientations of ATF2-Jun heterodimer binding and 
are not involved in any direct contact with DNA or the DNA-binding domain of IRF3 
(12).  Therefore, opposite orientations of heterodimer binding were predicted to cause a 
large change in distance between a fluorophore attached on the amino-terminal side of 
the basic region of ATF2 or Jun and a fluorophore attached to the end of the IFNb 
oligonucleotide.           
 Proteins encompassing amino acid residues 322-397 of ATF2 [Fig. 2.6B, bATF2], 
240-315 of Jun [Fig. 2.6B, bJun], 1-111 of IRF3 (iIRF3), 1-107 of HMGI (full-length) 
were expressed as His-SUMO fusions in Rosetta2 competent cells (Novagen) induced 
with 1 mM IPTG for 3 h at 37°C.  Proteins were purified from cell lysates by nickel 
chelate affinity chromatography in the presence of 6M guanine-hydrochloride (10).  The 
guanine-extracted proteins were renatured at 4°C by dialyses using 8-kDa molecular 
mass cutoff membranes in 1) 25 mM succinate pH 4, 10% glycerol, 5 mM β-
mercaptoethanol, and 1 M guanidine hydrochloride for at least 2 h, 2) 25 mM succinate 
pH 4, 10% glycerol, 1 mM DTT, and 0.1 M guanidine hydrochloride at least 1 h, 3) 25 
mM succinate pH 4, 10% glycerol, 1mM DTT at least 3 h, and 4) 25 mM succinate pH 4, 
10% glycerol, 1mM DTT overnight.  The His-SUMO tag was removed by incubation 
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with His-tagged ULP1 protease in a reaction buffer containing 0.5M tris-HCl pH 8, 2% 
NP-40, 10 mM DTT, and 1.5 M NaCl for at least 24 hours at 4°C.  The cleaved proteins 
were then purified from His-SUMO and His-ULP1 by nickel chelate affinity 
chromatography using an equilibration/elution buffer containing high salt (25 mM tris-
HCl pH 8, 5% glycerol, 1mM DTT, 10 mM imidazole pH 8, and 1M NaCl) in order to 
prevent retention of the cleaved proteins on the column.  3-kDa molecular mass cutoff 
Microcon columns were used for salt removal and protein concentration according to the 
manufacturer’s protocol (Millipore, Inc.).  The proteins were eluted with a buffer 
containing of 25 mM succinate pH 4, 10% glycerol, and 1 mM DTT. 
 bATF2 and bJun proteins used for labeling were treated with 25 mM β-
mercaptoethanol for 10 minutes at room temperature and dialyzed at 4°C in buffer 
containing 0.2M NaPO4 pH 8, 6M guanidine-hydrochloride, 0.5M EDTA, and 200 μM 
DTT overnight.  Following dialysis, the buffer was exchanged for a buffer containing 6M 
guanidine-hydrochloride, 50 mM tris-HCl, and 700 μM TCEP (adjusted to pH 7.4) using 
size exclusion chromatography.  During labeling, Texas red’s thiol-reactive 
bromoacetamide functional group alkylates the thiols present on the protein’s cysteine 
residues to generate chemically stable thioethers. Therefore, I treated the protein with β-
mercaptoethanol and dialyzed in the initial buffer to ensure optimal reduction of thiol-
groups, and then substituted DTT with TCEP and reduced the pH from 8 to 7.4 in the 
second buffer in order to eliminate competition with the label for the protein’s thiol group 
and prevent amine labeling, respectively, while still maintaining a reduced state.    
 The proteins were labeled on unique cysteine residues appended to the amino-
terminal ends [Fig. 2.6] with a 20-fold molar excess of Texas red C5 bromoacetamide 
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(Molecular Probes, Eugene, OR) added dropwise while lightly vortexing the protein in an 
amber-colored tube.  Labeling reactions were carried out for at least 3 h at room 
temperature and overnight at 4°C.  Excess dye was removed using size exclusion 
chromatography.  Removal of the remaining dye was accomplished by performing 
extensive dialyses in the dark over several days in 25 mM succinate pH 4, 10% glycerol, 
and 3 M guanidine hydrochloride.  Renaturation was performed in the dark at 4°C by 
dialyses in 1) 25 mM succinate pH 4, 10% glycerol, and 1 M guanidine hydrochloride for 
at least 2 h, 2) 25 mM succinate pH 4, 10% glycerol, and 0.1 M guanidine hydrochloride 
at least 1 h, 3) 25 mM succinate pH 4 and 10% glycerol at least 3 h, and 4) 25 mM 
succinate pH 4, 10% glycerol overnight.  The proteins were analyzed by SDS-PAGE and 
concentrations were measured using Bradford reagent (Bio-Rad, Hercules, CA). 
 
IV.B.  Heterodimer-DNA complex formation and separation by PAGE 
 
 
 Complexes are formed by incubation of heterodimers containing one subunit 
labeled with a TR acceptor with oligonucleotides (500 nM) labeled with a FAM donor on 
either end. A 2:1 molar ratio of Jun to ATF2 is used to minimize the formation of ATF2 
homodimer complexes. To obtain more than 50% binding of the labeled oligonucleotides 
after gel electrophoresis, the proteins were used at 500 nM dimer. The protein 
concentration and the amount of complex formed did not influence the end preference 
values. The heterodimers and IFNb oligonucleotides were incubated for 10 min at room 
temperature in a binding buffer containing of 20 mM Hepes, pH 7.6, 100 mM KCl, 5% 
glycerol, 1 mM EDTA, 5 mM DTT, 0.5 mg/ml bovine serum albumin, 0.1% (w/w) 
Nonidet P-40, and 0.1 mg/ml poly(dI-dC). The ATF2–Jun heterodimer complexes were 
 69
separated from ATF2 homodimer complexes and free DNA by native 8% PAGE in a gel 
buffer containing 25 mM Tris, 195 mM glycine for 2 h in the dark at 4C and 300 V. The 
gels were prepared between low-fluorescence glass plates (C.B.S. Scientific Co.) to 
minimize background when scanning. The total background including the contribution 
from thin polyacrylamide gels was generally very low, accounting for approximately 2% 
of the signal. 
 
IV.C.  Detection of fluorescence emissions 
 
 
 The gelFRET assay requires the use of a fluorescence imaging instrument that 
allows measurement of the donor and acceptor emissions at each position of the gel. A 
488-nm laser beam is directed to each position across the gel by a galvanometer-
controlled mirror. When the laser beam hits a spot containing a fluorophore, the 
fluorophore emits light with a characteristic spectrum. In complexes where the donor and 
acceptor fluorophores are in close proximity, a portion of the excitation energy from the 
donor fluorophore is transferred to the acceptor fluorophore. The emitted light from both 
donor and acceptor fluorophores is collected by a fiberoptic bundle and is passed through 
emission filters. Subsequently, a photomultiplier tube detects the light that passes through 
the filters and differences in signal intensity are used to produce a digital image.  
 To separate the donor and acceptor fluorescence emissions, the gel is scanned 
twice times using different emission filters (donor emission filter and acceptor emission 
filter) and the data are collected in a pixel-by-pixel alignment for each scan. Thus, both 
donor and acceptor fluorescence emissions can be determined for each nucleoprotein 
complex resolved by gel electrophoresis.   
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CHAPTER 3:  STRUCTURAL MECHANISM OF COOPERATIVE DNA-
BINDING BY iIRF3 AND NON-ORIENTED bATF2-bJUN HETERODIMERS AT 
THE INTERFERON-β ENHANCER  
 
 
 
I.  INTRODUCTION 
 
 
 
I.A.  Atomic modeling of bATF2-bJun-iIRF3 complexes 
 
 
 
 The simplest model to account for the observations that both orientations of 
bATF2-bJun heterodimers as well as bATF2 and bJun homodimers cooperated with 
iIRF3 at IFNb is that iIRF3 can contact structurally related amino acid residues in both 
bATF2 and in bJun.   Therefore, we examined the crystal structure for potential 
symmetrical heterodimer interactions with iIRF3.  Additionally, since regions in the N-
terminal domains of ATF2 and Jun that would fall proximal iIRF3 were missing from the 
crystal structure, we extended the N-terminal ends of the basic-region alpha helices of 
Jun and ATF2 to include 14 additional residues.     
 
I.A.i.  Potential amino acid interactions in the left half-site 
 
 R345 in ATF2 contacts D45 in IRF3 in the ATF2-Jun-IRF3-IFNb crystal 
structure where ATF2 binds to the left half-site [Fig 3.1, upper left panel] (6).  R263 in 
Jun is located at a symmetry-related position related to R345 in ATF2 by a 180° rotation 
about the dimer axis [Fig 3.1, lower left panel].  R263 in Jun could therefore contact D45 
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in iIRF3 when the heterodimer binds in the opposite orientation.  This model predicts that 
substitution of R345 in bATF2 versus R263 in Jun should have opposite effects on the 
orientation of bATF2-bJun binding at IFNb in association with iIRF3. 
 
 
Fig. 3.1. Molecular models for interaction interfaces in iIRF3 and the bATF2-bJun heterodimer.  The 
model contains fourteen additional α-helical amino acid residues on the amino-terminal sides of the basic-
regions of ATF2 and Jun compared to the fragments used for crystalization.  The upper left panel shows the 
contact between D45 of IRF3 and R345 in ATF2. The bottom left panel shows the symmetry-related R263 
residue in bJun, which could contact D45 when the heterodimer binds in the opposite orientation.   The 
upper right panel shows potential electrostatic interactions between K70 of IRF3 and negatively charged 
residues adjacent to the basic region in Jun.  The lower right panel depicts the symmetry-related negatively 
charged residues in bATF2, which could interact with K70 when the heterodimer binds in the opposite 
orientation.  The figure was created using the PyMOL Molecular Graphics System (3) and coordinates 
from the RCSB Protein Data Bank [www.pdb.org (1), PDB ID: 1T2K] in agreement with the published 
structure (6). 
 
II.A.ii.  Potential amino acid interactions in the right half-site 
 
 To identify additional interactions between bATF2-bJun and iIRF3 that could 
affect heterodimer orientation, we examined the roles of amino acid residues on the 
amino-terminal sides of the bZIP domains of ATF2 and Jun.  Both bATF2 and bJun 
contain a cluster of negatively charged residues adjacent to their basic regions (E331, 
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D332, D334, E335 in bATF2 and D246, E248, E251 in bJun).  Modeling of the residues 
adjacent to the basic regions by extension of the basic region α-helices in ATF2 and Jun 
showed that these residues in Jun are in close proximity to K70 of IRF3 [Fig. 3.1, upper 
right panel] and that these residues in ATF2 are in a similar position relative to K70 of 
IRF3 when the heterodimer binds to DNA in the opposite orientation [Fig. 3.1, lower 
right panel].  
 
II.  RESULTS AND DISCUSSION 
 
 
II.A.  GelFRET analysis of XD substitutions in bATF2 and bJun 
 
 
To test the roles of potential interactions between iIRF3 and either bATF2 or bJun 
in the orientation of heterodimer binding at IFNb, we examined the effects of R345A 
substitution in bATF2 (bATF2XD) and R263A substitution in bJun (bJunXD) on the 
orientation of heterodimer binding in the presence and absence of iIRF3. The 
substitutions in bATF2XD and bJunXD had small effects on the orientation of 
heterodimer binding in the absence of iIRF3 [Fig. 3.2A]. In complexes formed with 
iIRF3, the R345A substitution in bATF2 reversed the orientation of bATF2XD-bJun 
binding compared with wild-type heterodimers [Fig. 3.2B].  Conversely, the R263A 
substitution in bJun enhanced the opposite orientation preference of bATF2-bJunXD 
compared with wild type heterodimers in complexes formed with iIRF3 [Fig. 3.2B].  
 Thus, whereas iIRF3 had a minimal effect on the orientation preference of wild-
type bATF2-bJun binding at IFNb, iIRF3 caused opposite shifts in the orientation 
preferences of bATF2XD-bJun and bATF2-bJunXD binding at IFNb [compare the end 
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preference values of each heterodimer between Fig. 3.2A and 3.2B].  In each case, the 
shift in the heterodimer orientation preference caused by iIRF3 binding reflected a 
decrease in binding by the mutated (XD) subunit to the left IFNb half-site proximal to 
D45 of iIRF3 and a corresponding increase in binding by the wild type subunit to the left 
half-site.  These results are consistent with contacts between the wild type R263 of bJun 
or R345 of bATF2 with D45 of iIRF3 at the left IFNb half-site.  Simultaneous 
substitution of both amino acid residues in bATF2 and bJun (bATF2XD-bJunXD)  
 75
0.3
0.4
0.5
0.6
0.7
0.8
0.4
0.5
0.6
0.7
0.8
0.9
0.4
0.5
0.6
0.7
0.8
0.9
En
d 
Pr
ef
er
en
ce
L
R
XK
ATF2 ATF2 ATF2 ATF2 ATF2 ATF2 ATF2
XKXDXD
JUN JUN JUN JUN JUN JUN JUN
XKXDXD XK
RR AR AR AA RR
A
RR
AA
RR
A
En
d 
Pr
ef
er
en
ce
L
R
XK
ATF2 ATF2 ATF2 ATF2 ATF2 ATF2 ATF2
XKXDXD
JUN JUN JUN JUN JUN JUN JUN
XKXDXD XK
IRF3
RRD
K
ARD
K
ARD
K
AAD
K
RRD
KA
RRD
KAA
RRD
KA
En
d 
P r
ef
er
en
ce
L
R
XK
ATF2 ATF2 ATF2 ATF2 ATF2 ATF2 ATF2
XKXDXD
JUN JUN JUN JUN JUN JUN JUN
XKXDXD XK
IRF3K70E
RRD
E
ARD
E
ARD
E
AAD
E
RRD
EA
RRD
EAA
RRD
EA
A
B
C
 
Fig. 3.2. Substitution of symmetry-related amino acid residues in bATF2 versus bJun shifts the 
orientation of heterodimer binding in opposite directions in complexes formed with iIRF3 at IFNb.  
(A) GelFRET analysis of the effects of symmetry-related amino acid substitutions in bATF2 and bJun on 
the orientation of heterodimer binding at IFNb. The orientations of heterodimer binding were analyzed for 
complexes formed with (B) iIRF3, (C) iIRF3K70E.  The diagrams below the bars reflect the preferred 
orientation of heterodimer binding using the symbols described in Fig. 2.1.  The data shown represent the 
mean values and standard deviations from at least two independent experiments.  
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eliminated the effect of iIRF3 on the orientation of heterodimer binding [compare Fig. 
3.2A and 3.2B].  These observations indicate that R345 in ATF2 and R263 in Jun have 
opposing effects on the orientation of bATF2-bJun binding at IFNb in association with 
iIRF3.   
 We attempted to determine the effects of D45A and D45R substitutions in iIRF3 
on the orientation of heterodimer binding.  Both D45A and D45R substitutions reduced 
the intrinsic affinity of iIRF3 with IFNb (data not shown). The reduced levels of bATF2-
bJun-iIRF3-IFNb complexes formed by these iIRF3 mutants prevented determination of 
the effects of these mutations in IRF3 on the orientation of bATF2-bJun binding  at IFNb. 
 
II.B.  GelFRET analysis of XK substitutions in bATF2 and bJun 
 
 The amino acid substitutions in bATF2XD and bJunXD that could alter contacts 
with D45 in IRF3 had smaller effects on heterodimer orientation preference than the 
amino acid substitutions in bATF2XG and bJunXG that could alter contacts with the 
central asymmetric guanine.  To identify additional interactions between bATF2-bJun 
and iIRF3 that could affect heterodimer orientation, we examined the roles of amino acid 
residues on the amino-terminal sides of the bZIP domains of ATF2 and Jun.  Both bATF2 
and bJun contain a cluster of negatively charged residues adjacent to their basic regions 
(E331, D332, D334, E335 in bATF2 and D246, E248, E251 in bJun).  Modeling of the 
residues adjacent to the basic regions by extension of the basic region α-helices in ATF2 
and Jun suggested that these residues were in the vicinity of K70 of iIRF3 in the 
heterodimer subunit bound to the right half-site.  We examined the effects of substituting 
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these residues by alanines either in bATF2 (bATF2XK) or in bJun (bJunXK) on 
heterodimer orientation in the presence and absence of iIRF3.      
 In the absence of iIRF3, replacement of the negatively charged residues adjacent 
to the basic region of bATF2 resulted in a lower orientation preference of bATF2XK-
bJun heterodimers compared with that of wild type heterodimers at IFNb [Fig. 3.2A].  
The corresponding substitutions in bJun had little effect on the orientation of bATF2-
bJunXK heterodimer binding.  In complexes containing iIRF3, these substitutions in 
bATF2 increased the orientation preference of bATF2XK-bJun heterodimer binding 
compared with that of wild type heterodimers at IFNb [Fig. 3.2B].  Conversely, in 
complexes containing iIRF3, these substitutions in bJun eliminated the orientation 
preference of bATF2-bJunXK binding at IFNb.  Thus, iIRF3 caused opposite shifts in the 
orientation preferences of bATF2XK-bJun and bATF2-bJunXK binding at IFNb 
[compare the end preferences of each complex between Fig. 3.2A and Fig 3.2B].   
 In each case, the shift in the orientation of heterodimer binding reflected a 
decrease in binding by the mutated (XK) subunit to the right half-site proximal to K70 of 
iIRF3 and a corresponding increase in binding by the wild type subunit of each 
heterodimer to the right half-site in which the remaining negatively charged residues 
could interact with K70 of iIRF3.  As expected, simultaneous substitution of both clusters 
of negatively charged residues in bATF2XK-bJunXK reduced the effect of iIRF3 binding 
on heterodimer orientation compared to heterodimers in which residues in only one 
subunit were substituted.  These results indicate that residues E331, D332, D334, or E335 
in bATF2 and residues D246, E248, or E251 in bJun had opposing effects on the 
orientation of bATF2-bJun binding at IFNb in association with iIRF3.  
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K70 in iIRF3 was predicted to interact with the negatively charged residues in 
either bJun or bATF2, depending on the orientation of heterodimer binding.  We tested if 
replacement of K70 in iIRF3 with glutamate (iIRF3K70E) altered the effects of the 
negatively charged amino acid residues adjacent to the basic regions in bJun and bATF2 
on heterodimer orientation. In complexes formed with iIRF3K70E, the bATF2XK-bJun 
and bATF2-bJunXK heterodimers had orientation preferences at IFNb that were 
indistinguishable from their orientation preferences in the absence of iIRF3 [compare the 
end preferences of each complex between Fig. 2D and Fig. 2B]. Thus, the K70E 
substitution in iIRF3 eliminated the effects of iIRF3 on the orientation preferences of 
bATF2XK-bJun and bATF2-bJunXK heterodimers at IFNb. The K70E substitution also 
eliminated the effects of iIRF3 on the orientations of heterodimers containing individual 
alanine substitutions at either E331, D332, D334, or E335 in bATF2 or residues D246, 
E248, or E251 in bJun (data not shown).  In contrast, iIRF3K70E caused the same shifts 
in the orientations of bATF2XD-bJun and bATF2-bJunXD binding at IFNb as those that 
were caused by wild type iIRF3.  These results suggest that the negatively charged 
residues adjacent to the basic regions of bATF2 and bJun affected heterodimer 
orientation through mutually exclusive interactions with K70 of iIRF3 at the right half-
site of IFNb. 
 
II.C.  Quantitative gel-shift analysis of heterodimer-iIRF3 interactions 
 
 
 We investigated if the amino acid residues in bATF2, bJun and iIRF3 whose 
interactions affected the orientation of heterodimer binding also affected the affinity of 
complex formation at IFNb.  We compared affinities of wild type iIRF3, iIRF3(D45A), 
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and iIRF3(K70A) association with wild type bATF2-bJun heterodimer at IFNb [Fig. 
3.3A].  We also compared the affinities of wild type iIRF3, iIRF3(D45A) and 
iIRF3(K70A) association with heterodimers containing symmetrical amino acid 
substitutions in the basic region [Fig. 3.3B, bATFXD-bJunXD] and adjacent to the basic 
region [Fig. 3.3C, bATF2XK-bJunXK] at IFNb.  The K70A substitution in iIRF3 slightly 
reduced association with wild type bATF2-bJun, severely reduced association with 
bATF2XD-bJunXD, and slightly enhanced association with bATF2XK-bJunXK at IFNb.  
In contrast, the D45A substitution in iIRF3 severely reduced association with wild-type 
bATF2-bJun, moderately reduced association with bATF2XD-bJunXD, and most 
severely  reduced association with bATF2XK-bJunXK at IFNb.   
 Simultaneous substitution of D45A and K70A in iIRF3 eliminated detectable 
association with bATF2-bJun at IFNb (data not shown).  Likewise, simultaneous 
substitution of the amino acid residues in bATF2 and bJun predicted to interact with 
iIRF3 (bATF2XDXK-bJunXDXK) eliminated detectable iIRF3 association with the 
heterodimer at IFNb (data not shown).  These results indicate that interactions between 
K70 in iIRF3 and the symmetry-related negatively charged residues adjacent to the basic 
regions of bATF2 (E331, D332, D334, and E335) and bJun (D246, E248, E251) stabilize 
iIRF3 binding at IFNb and interactions between D45 in iIRF3 and the symmetry-related 
arginines in the basic regions of bATF2 (R345) and bJun (R263) are the primary 
determinates of the recruitment of iIRF3 to IFNb by bATF2-bJun.   
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Fig. 3.3. Symmetrical amino acid substitutions in bATF2 and bJun influence the relative affinities of 
different iIRF3 variants at IFNb.  The indicated concentrations of iIRF3, iIRF3D45A, and iIRF3K70A 
were incubated with IFNb [25 nM] and either (A) bATF2 [35 nM] and bJun [70 nM], (B) bJunXD[35nM] 
and bATF2XD [70 nM], or (C) bJunXK [35 nM] and bATF2XK [70 nM].  The complexes were separated 
by gel electrophoresis and the fraction of the heterodimer-IFNb complexes bound by the wild type or 
mutant iIRF3 was plotted as a function of iIRF3 concentration.   The data was fit with sigmoidal logistic 
curves using SigmaPlot.   
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II.D.  Effect of HMGI on interactions in the complex 
 
 
 HMGI binding reduced the orientation preference of bATF2-bJun association 
with iIRF3 at IFNb [Fig 2.1E].  We investigated whether HMGI binding affected 
heterodimer orientation by altering bATF2-bJun interactions with iIRF3, or through 
independent mechanisms.  Substitution of R345 of bATF2 (bATF2XD) or R263 of bJun 
(bJunXD) had opposite effects on heterodimer orientation both in complexes containing 
HMGI and iIRF3 and those containing iIRF3 alone [compare Fig. 3.4A and 3.2B].  
HMGI therefore did not alter the effects of these symmetry-related amino acid 
substitutions on heterodimer orientation.  
In contrast, substitution of the negatively charged residues adjacent to the basic 
region of bATF2 (bATF2XK) or bJun (bJunXK) had a large effect on heterodimer 
orientation in complexes containing iIRF3 alone, but almost no effect in complexes 
containing iIRF3 together with HMGI [compare Fig. 3.2B and 3.4A].  Therefore, amino 
acid substitutions in bATF2 and bJun that altered heterodimer interactions with D45 of 
iIRF3 had equivalent effects on heterodimer orientation in the presence or absence of 
HMGI, whereas the amino acid substitutions that altered heterodimer interactions with 
K70 of iIRF3 had distinct effects in the presence of HMGI. 
We compared the effects of the K70E substitution in IRF3 on heterodimer 
orientation in the presence and absence of HMGI to determine if HMGI altered bATF2-
bJun interactions with K70 of iIRF3.  The K70E substitution had opposite effects on the 
orientations of bATF2XK-bJun and bATF2-bJunXK heterodimers both in complexes 
containing HMGI and in those lacking HMGI. Likewise, the K70E substitution had no 
detectable effects on the orientations of bATF2-bJun, bATF2XD-bJun, bATF2-bJunXD, 
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bATF2XD-bATF2XD, or bATF2XK-bATF2XK heterodimers either in complexes 
containing HMGI or in those lacking HMGI (compare Fig. 3.2B with 3.2C and 3.4A with 
3.4B).  Thus, HMGI did not alter the effects of interactions with K70 in iIRF3 on 
heterodimer orientation.  The distinct effects of amino acid residues in bATF2 and bJun 
that can contact K70 of iIRF3 on heterodimer orientation in the presence versus the 
absence of HMGI were therefore independent of K70 of iIRF3.  
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Fig. 3.4. K70E substitution in iIRF3 preferentially influences the orientation preference of 
bATF2XK-bJun and bATF2-bJunXK heterodimers in complexes containing HMGI.  Effects of 
symmetry-related amino acid substitutions in bATF2 and bJun on the orientation of heterodimer binding at 
IFNb in complexes formed with (A) iIRF3 and HMGI and (B) iIRF3K70E and HMGI were analyzed by 
gelFRET.  The diagrams below the bars reflect the preferred orientation of heterodimer binding using the 
symbols described in Fig. 2.1.  The data shown represent the mean values and standard deviations from at 
least two independent experiments. 
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III.  SUMMARY AND CONCLUSIONS 
 
 
 Our results demonstrate that ATF2-Jun-IRF3-HMGI complexes bind 
cooperatively to the interferon-b enhancer in different configurations.  These results 
establish that the structural organization of multi-protein transcription regulatory 
complexes can be more variable than predicted by previous studies.  Previous studies 
using different experimental approaches have produced results consistent with opposite 
orientations of ATF2-Jun association with IRF3 proteins at IFNb (5, 6).  It has also been 
reported that ATF2 and Jun do not bind cooperatively with IRF3 to the interferon-b 
enhancer (4).  The contrasting conclusions from different studies of the orientation of 
ATF2-Jun heterodimer binding in association with IRF3 at the interferon-β enhancer are 
consistent with our observation that bATF2-bJun can bind the interferon-β enhancer in 
both orientations in association with IRF3.        
 This unexpected flexibility of ATF2-Jun association with IRF3 is due to the 
presence of charged residues at symmetry-related positions in ATF2 and in Jun that can 
contact IRF3.  Electrostatic interactions between these residues mediate both the opposite 
orientations of bATF2-bJun binding as well as the stabilization of IRF3 binding at the 
interferon-b enhancer.   The redundancy of the interacting residues in ATF2 and Jun is 
also consistent with the previous observation that substitution of these residues in ATF2 
does not eliminate cooperative DNA binding with IRF3 (6).  Consequently, cooperative 
DNA binding by ATF2 and Jun with IRF3 and HMGI does not require or fix a unique 
orientation of heterodimer binding. 
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IV.  MATERIALS AND METHODS 
 
 
IV.A.  Generation of alanine-substituted proteins 
 
 
 In order to determine the role of specific amino acid residues in bATF2, bJun, and 
iIRF3 in cooperative DNA-binding interactions between bATF2-bJun and iIRF3, alanine 
codon substitutions in bATF2, bJun, and iIRF3 expression vectors were introduced using 
QuikChange II site-directed mutagenesis kit  (Strategene Inc., La Jolla, CA). bATF2XK 
contained alanine substitutions at amino acid residues E331, D332, D334, and E335, 
bATF2XD contained an alanine substitution at amino acid residue R345, bJunXK 
contained alanine substitutions at amino acid residues D246, E248, and E251, and 
bJunXD contained an alanine substitution at amino acid residue R263 [Fig 3.5].  SUMO-
fusion proteins containing the alanine substitutions were expressed and purified in 
parallel with wild-type proteins (see Chapter 2 Materials and Methods). 
 
  
 
 
 
 
Fig. 3.5. Design of alanine substituted bATF2 and bJun proteins. Diagram illustrating locations of 
charged amino acid residues in bATF2 and bJun (shown in green font) substituted by alanine.  Amino acid 
residues in bATF2 and bJun that were included in the crystal structure (6) are depicted as alpha-helices 
whereas residues not included in the crystal structure are depicted as coils.  The amino-terminal cysteine 
residues used for labeling with TR are indicated by red font.   
 
 
 
 85
IV.B.  Quantitative gel-shift analysis of cooperative DNA-binding 
 
 
 Gel mobility shift assays are routinely used to visualize protein-nucleic acid 
interactions.  Quantitative applications of this method enable determination of the 
thermodynamic properties of protein-nucleic acid complexes.  Assay designs can include 
titration, competition, and stoichiometry experiments.  For the analyses of the role of 
specific amino acid contacts between bATF2-bJun and iIRF3 in cooperative DNA-
binding, I have utilized titration experiments in order to determine relative affinities of 
wild-type versus alanine-substituted iIRF3 for heterodimer-DNA complexes containing 
different alanine substitutions.   
 
IV.B.i.  Oligonucleotide labeling 
 
 5’-6-FAM-labeled sense and anti-sense IFNb oligonucleotide containing the 
sequences shown in figure 2.6 was synthesized by Integrated DNA Technologies, Inc. 
(Coralville, IA).  Double-labeled IFNb duplexes were prepared by annealing 5’-labeled 
IFNb sense strands to 5’-labeled IFNb anti-sense strands (4 mg/ml duplex) in the 
presence of 10 nM KCl by heating to 95°C for a few minutes in a water bath and then 
slowly reducing the temperature to 25°C.  The duplexes were separated by single strands 
by 5% PAGE in 25 nM Tris, 195 mM glycine gel buffer run for 2 h at room temperature.  
The labeled duplex bands were visualized using an UV transilluminator and excised.  
Subsequently, the annealed duplexes were recovered by overnight incubation in TE 
buffer at 37°C.  The concentrations of the duplexes were determined 
spectrophotometrically at 260 nm. 
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IV.B.ii.  Titrations with iIRF3 and separation by PAGE 
 
 This gel mobility shift assay relies on the property that nucleic acids will migrate 
through a gel matrix towards an anode upon application of an electric field.  The 
migration through the gel is governed by four primary properties: the molecular weight, 
charge, and three-dimensional shape of the nucleic acid as well as the physical properties 
of the gel substrate.  Interaction with a protein that modulates the nucleic acid 
conformation or substantially increases the molecular weight can lead to differential 
mobility in the gel.  The choice of the gel matrix can amplify or dampen this effect 
depending upon the size and shape of the protein-DNA complex.  By this approach, the 
formation of bATF2-bJun-iIRF3-IFNb complexes can be monitored by comparing the 
mobility of bATF2-bJun-IFNb complexes in the presence and absence of iIRF3. 
Differential mobilities if bATF2-bJun-IFNb complexes in the presence versus absence of 
iIRF3 is indicative of an interaction between iIRF3 and bATF2-bJun-IFNb complexes.   
 This type of experiment is often performed with a single concentration of protein 
and is sufficient to corroborate binding observed in a separate method.  However, a single 
concentration is not suitable to compare the binding properties of different nucleic acid-
binding complexes.  This is because the fraction of bound nucleic acid is sensitive to 
changes in protein concentration for only a narrow range surrounding the equilibrium 
dissociation constant.  For experiments that utilize only one protein concentration, this 
insensitivity can lead to serious misinterpretations of relative binding affinities. 
 The concentrations of bATF2, bJun, iIRF3, and IFNb used in the assay must be 
limiting (sub-saturating) in order to ensure affinity-dependent (rather than concentration-
dependent) binding of iIRF3. Under ideal conditions, the total molar concentration of all 
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of the components should be 10- to 100- fold less than the dissociation constant of the 
binding protein.  Conversely, weak interactions are difficult to measure because 
significant dissociation of the protein-DNA complex can occur during the time that is 
takes to load and run the gel.  Dissociation can lead to smearing of the bound species and 
difficulty in quantification, and equilibrium dissociation constants greater than 1-3 μM 
typically cannot be accurately determined.  Previous fluorescence anisotropy analyses of 
the binding of IRF3 to different length interferon-β enhancer elements in the absence or 
presence of ATF2-Jun heterodimers have produced binding constants in the low 
micromolar range (2, 4).    Therefore, I predicted that the affinity of iIRF3 binding to 
bATF2-bJun-IFNb complexes could be feasible using gel-shift fluorescence 
measurements which, in my hands, can yield precise measurements using ~100 nM total 
concentration of components.   Rather than calculate actual dissociate constant values, I 
have analyzed different titration experiments in the same gel in order to estimate relative 
binding affinities. 
 The protein concentration stocks should be prepared by serial dilution in order to 
minimize variation and pipette error that can skew results.  The final concentration series 
used for the measurement should be chosen to maximize the number of data points within 
the binding transition. bATF2-bJun-DNA complexes formed from 93.75nM bJun, 
46.875nM bATF2 and 25nM IFNb probe (labeled with FAM on both ends) was titrated 
with up to 490nM of iIRF3.   
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IV.B.iii.  Quantification of fraction of complexes bound 
 
 The fraction of bound heterodimer-IFNb complexes was estimated by dividing the 
background-corrected intensity of the bATF2-bJun-iIRF3-IFNb (bound) band by the sum 
of background-corrected intensities of the bATF2-bJun-IFNb (unbound) and bATF2-
bJun-iIRF3-IFNb bands. 
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CHAPTER 4:  FUNCTIONAL EFFECTS OF ORIENTED HETERODIMER 
BINDING IN VITRO AND IN VIVO 
 
 
I.  INTRODUCTION 
 
 
I.A.  Control of the orientation of heterodimer binding 
 
 
 Previous investigations of the functional role of bZIP heterodimer orientation in 
in vivo have required manipulations of the DNA recognition element, thus precluding 
analysis of the effects of heterodimer binding orientation at endogenous genomic loci (2, 
18). By utilizing ATF2 and Jun substitutions which force asymmetric heterodimer 
interactions with either the DNA (XG substitutions) or with IRF3 (XD and XK 
substitutions) we have developed parallel strategies for manipulating heterodimer 
orientation at IFNb oligonucleotides in vitro and at the endogenous interferon-β enhancer 
element in vivo, thus allowing more biologically relevant insights into the role of 
alternative bZIP heterodimer binding orientations in transcriptional regulation.   
 We investigated whether the amino acid substitutions in bATF2 and bJun that 
individually affected heterodimer orientation in association with iIRF3 affected the 
orientation of heterodimer binding in concert.  Simultaneous substitution of the arginine 
in the basic region of one subunit (XD) and the negatively charged residues adjacent to 
the basic region in the other subunit (XK) was predicted to eliminate interactions with 
both K70 and D45 in iIRF3 when the heterodimer bound in one orientation but not to 
affect these interactions when the heterodimer bound in the opposite orientation. In 
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complexes lacking iIRF3, bATF2XD-bJunXK heterodimers bound IFNb with a stronger 
orientation preference than wild type bATF2-bJun [Fig. 4.1, left panel].  The orientation 
of bATF2XD-bJunXK at IFNb was reversed by iIRF3 binding. The resulting complex  
 
Fig. 4.1.  Combinations of amino acid substitutions in bATF2 and bJun have concerted effects on the 
orientation of heterodimer binding in association with iIRF3 and HMGI.  Effects of combinations of 
asymmetric amino acid substitutions in bATF2 and bJun on the orientation of heterodimer binding alone 
(left panel), in association with iIRF3 (middle panel), and in association with iIRF3 and HMGI (right 
panel).  The orientations of heterodimer binding at IFNb in complexes formed by the proteins indicated 
above the lanes were analyzed as described in Fig. 2.1. The diagrams below the bars reflect the preferred 
orientations of heterodimer binding using the symbols described in Fig. 2.1.  The end preference values 
represent the mean values and standard deviations from at least two independent experiments.  
 
had a stronger orientation preference than those of complexes formed by heterodimers 
containing either of the individual substitutions (bATF2XD-bJun or bATF2-bJunXK).  
 Conversely, iIRF3 binding caused the opposite shift in the orientation of 
bATF2XK-bJunXD at IFNb [Fig. 4.1, middle panel]. The resulting complex had a 
stronger orientation preference than those of complexes former by heterodimers 
 92
containing either of the individual substitutions (bATF2XK-bJun or bATF2-bJunXD). 
These combinations of amino acid substitutions also had opposite effects on the 
orientations of bATF2-bJun heterodimer binding in complexes containing iIRF3 and 
HMGI [Fig. 4.1, right panel].  The effects of combined XD and XK substitutions on 
heterodimer orientation preference in the presence of either iIRF3 or HMGI and iIRF3 
were comparable to the effects of XG substitutions in the same complexes. Thus, 
simultaneous contacts by the arginine in the basic region of the subunit bound to the left 
half-site and by the negatively charged residues adjacent to the basic region of the subunit 
bound to the right half-site with D45 and K70 of iIRF3, respectively, are the primary 
determinants of heterodimer orientation preference in the presence of iIRF3.   
 
I.B.  Regulation of interferon-β expression in cells 
 
 The first response of an organism to intruding pathogens is an inflammatory 
reaction that includes secretion of cytokines and chemokines.  During viral infections, 
some of the most prominent cytokines produces are the interferons.  Interferons have 
numerous regulatory functions that affect both innate and adaptive immunity (13).  
Interferons are classified as type I (interferon-α and interferon–β) and type II (interferon-
γ) based on the receptor complex that they activate.  In epithelial and fibroblast cells, 
interferon-β is expressed and secreted within hours following virus infection and triggers 
the expression of interferon-α in an autocrine fashion (10, 19).  Therefore, the regulation 
of interferon-β expression is a crucial step in the induction of the type I interferon 
response. 
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I.B.i.  Model for Sendai virus-induced activation of interferon-β 
 
 Because the induction of interferon-β is so critical for the immune response, the 
mechanism underlying its control has been the subject of detailed study.   Interferon-β, 
like the interferon-α proteins, is regulated primarily at the transcriptional level (9). The 
enhancer region of the interferon-β gene contains at least four regulatory DNA sequences 
named positive regulatory domain I, II, III, and IV (4, 7, 8).  The PRDI and PRDIII 
elements are activated by members of the IRF family, whereas the PRDII and PRDIV are 
activated by NF-κΒ and ATF2-Jun heterodimers.   
 Studies of the transcriptional regulation of interferon-β have been mainly carried 
out using Sendai virus-infected fibroblast and epithelial cells (6, 14, 15, 21, 23, 25).  In 
this context, interferon-β transcription is first activated by signals that induce the 
activation and localization of IRF3, NF-kB, and ATF2-Jun to the interferon-β enhancer.  
IRF3 is expressed constitutively in a variety of cells and localized in the cytoplasm as an 
inactive monomer (22).  Virus-mediated phosphorylation of IRF3 induces IRF3 
activation, homodimerization, and translocation to the nucleus (22).  In the nucleus, IRF3 
is believed to form a complex with the co-activator CBP (20).  This activated form of 
IRF3 is also known to directly induce chemokine genes such as RANTES during viral 
infection (11).   
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II.  RESULTS AND DISCUSSION 
 
 
II.A.  Effects of orientation on complex formation 
 
 
 To investigate potential functional consequences of the orientation of heterodimer 
binding on complex assembly in vitro, we measured the effects of the amino acid 
substitutions in bATF2 and bJun that alter the orientation of heterodimer binding on the 
affinities of complex formation at IFNb in the presence of iIRF3 and HMGI.  I compared 
the fraction of bATF2-bJun-IFNb complexes bound by iIRF3 and HMGI separately and 
in combination when bATF2 and bJun contained substitutions that favored opposite 
orientations of heterodimer binding (bJun-bATF2XG versus bJunXG-bATF2, and 
bATF2XD-bJunXK versus bATF2XK-bJunXD). bATF2-bJun and iIRF3 formed more 
complexes when bATF2 occupied the left and bJun occupied the right IFNb half-site (Fig. 
4.2Ai, iii).  Similarly, bATF2-bJun and HMGI formed more complexes when bATF2 
occupied the left and bJun occupied the right IFNb half-site (Fig 4.2Bi, iii).  In the 
presence of HMGI, the concentration of iIRF3 that produced half-maximal binding was 
reduced 2-4-fold and there was no detectable difference in iIRF3 binding with bATF2-
bJun variants that favored opposite orientations of heterodimer binding (Fig. 4.2Aii).  In 
the presence of iIRF3, the concentrations of HMGI that produced half-maximal binding 
was slightly reduced fold and there was also no detectable difference in HMGI binding 
with bATF2-bJun variants that favored opposite orientations of heterodimer binding (Fig 
4.2Bii).  Thus, iIRF3 and HMGI cooperatively reduce the effect of heterodimer binding 
orientation on the stability of complex formation at IFNb, consistent with their 
cooperative reduction of bATF2-bJun orientation preference at IFNb.   
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Fig. 4.2. iIRF3 and HMGI cooperatively reduce the effect of bATF2-bJun orientation on the stability 
of complex formation at IFNb.  (A) bATF2 [35 nM] and bJun [70 nM] variants which form heterodimers 
that bind IFNb [25 nM] with opposite orientation preferences were titrated with iIRF3 in the absence (i, iii) 
or presence (ii, iv) of HMGI [112nM].  XG-substituted heterodimers were analyzed in (i, ii), and XD-XK- 
substituted heterodimers were analyzed in (iii, iv) (as indicated on the abscissa).  (B) bATF2 [35 nM] and 
bJun [70 nM] variants which form heterodimers that bind IFNb [25 nM] with opposite orientation 
preferences were titrated with HMGI in the absence (i, iii) or presence (ii, iv) of iIRF3 [70nM].  XG-
substituted heterodimers were analyzed in (i, ii), and XD-XK- substituted heterodimers were analyzed in 
(iii, iv) (as indicated on the abscissa).  The complexes were separated by gel electrophoresis and the 
fraction of complexes bound by either iIRF3 (A) or HMGI (B) was plotted as a function of iIRF3 or HMGI 
concentration, respectively. The data shown in B(i, iii) qualitatively represents at least four separate 
experiments.  All other data represents the mean values and standard deviations from at least two separate 
experiments. 
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II.B.  Analysis of endogenous interferon-β gene transcription 
 
 
 To investigate the role of the orientation of ATF2-Jun heterodimer binding in 
transcription regulation, we examined endogenous interferon-β gene transcription in cells 
that expressed full length ATF2 and Jun that contained the amino acid substitutions that 
altered the orientation of bATF2-bJun binding in vitro.  Interferon-β transcript levels 
were measured in HeLa cells transfected with plasmids encoding full-length ATF2 and 
Jun together with or without IRF3 following Sendai virus infection.  We examined the 
effects of amino acid substitutions predicted to alter the intrinsic heterodimer orientation 
preference (ATF2XG-Jun and ATF2-JunXG) as well as the effects of substitutions 
predicted to alter the orientation of heterodimer binding in association with IRF3 
(ATF2XK-JunXD and ATF2XD-JunXK) on the level of interferon-β transcripts.   
 In the absence of exogenous IRF3, amino acid substitutions in ATF2 and Jun had 
no significant effect on the level of interferon-β transcripts (Fig. 4.3, left panel).  In 
contrast, co-expression of exogenous IRF3 with heterodimers in which Jun was predicted 
to favor binding to the right half-site (ATF2XK-JunXD and ATF2-JunXG) produced a 
higher level of interferon-b transcripts than co-expression of IRF3 with heterodimers in 
which Jun was predicted to favor binding the left half-site (ATF2XD-JunXK and 
ATF2XG-Jun) (Fig 4.3, left panel). Taken together, the effects of amino acid 
substitutions that affect the orientation of heterodimer binding in vitro on interferon-β 
transcription in cells were consistent with a role for heterodimer orientation in the control 
of interferon-b transcription. 
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Fig. 4.3.  ATF2-Jun heterodimers that bind IFNb in opposite orientations in vitro have distinct 
effects on transcription of different endogenous genes. (A)  The levels of gene transcripts were 
measured in cells that expressed the proteins indicated below the bar graphs.  Transiently transfected HeLa 
cells were infected with Sendai virus and the transcript levels were measured 6 hours after infection.  
Transcript levels were measured in the same cells and were normalized to the level of GAPDH transcripts. 
The orientations of bATF2-bJun heterodimer binding at IFNb in association with iIRF3 are indicated by the 
diagrams above the bar graphs.  The levels of transcripts in cells that expressed heterodimers containing 
amino acid substitutions that favor Jun binding to the right versus the left half-site are shown by green and 
red bars, respectively.  The levels of interferon-b transcripts in cells that expressed wild-type ATF2-Jun are 
shown by white bars, and those in cells that expressed IRF3 alone, or no exogenous proteins are shown by 
black bars.  (B) The levels of gene transcripts were measured in cells transfected with different ratios of 
plasmids encoding the proteins indicated by the legend in the upper right.  The plasmid ratios for all 
combinations of ATF2 and Jun variants were 5:1, 3:1, 1:1, 1:3 and 1:5, respectively from the left to the 
right.  Transcript levels were measured in the same cells and were normalized to the level of RPL9 
transcripts.  All data show the mean and standard deviation of replicate qPCR reactions and are 
representative of at least two independent transfection experiments.    
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II.C.  Effects of ATF2-Jun substitutions on other genes 
 
 We investigated if the amino acid substitutions that affected ATF2-Jun 
heterodimer orientation at IFNb and interferon-β transcription also affected transcription 
of other genes.  We searched the human genome for sequences similar to the composite 
ATF2-Jun-IRF3-HMGI recognition sequence in the interferon-β enhancer.  We identified 
four sequences that contained 18 of the 19 base-pairs in the composite ATF2-Jun-IRF3 
recognition sequence in the interferon-β enhancer.  We focused on the LEPREL1-T1 
transcript (ENST00000437063), which is transcribed 100,225 base pairs downstream of 
an ATF2-Jun-IRF3 recognition sequence.  Because of the strict conservation of the 
recognition sequence, we predicted that the amino acid substitutions that affected the 
orientation of bATF2-bJun binding at IFNb in vitro would have the same effects on the 
orientation of ATF2-Jun binding at the site upstream of the LEPREL1-T1 transcript.   
 We measured the levels of LEPREL1-T1 transcripts in cells that expressed the 
ATF2 and Jun variants alone and in combination with IRF3. Cells that expressed IRF3 
together with the combinations of ATF2 and Jun variants that were predicted to favor Jun 
binding to the right half-site (ATF2-JunXG and ATF2XD-JunXK) produced a higher 
level of LEPREL1-T1 transcripts than cells that expressed IRF3 together with the 
combinations of ATF2 and Jun variants predicted to favor Jun binding to the left half-site 
(ATF2XG-Jun and ATF2XK-JunXD) [Fig. 4.3., left panel].  In the absence of IRF3 co-
expression, the amino acid substitutions in ATF2 and Jun produced smaller and opposite 
differences in the level of LEPREL1-T1 transcripts [Fig. 4.3., left panel].  LEPREL1-T1 
transcription was not induced by Sendai virus infection, indicating that the effects of the 
amino acid substitutions in ATF2 and Jun on transcription were not caused by differences 
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in signaling related to virus infection.  The parallel effects of mutations in ATF2 and Jun 
on the levels of interferon-β and LEPREL1-T1 transcripts are consistent with similar 
effects of the orientation of heterodimer binding on transcription of these genes. 
 We investigated if the amino acid substitutions in ATF2 and Jun also affected 
transcription of other genes that contained ATF2-Jun and IRF3 recognition sequences.  
The RANTES chemokine gene contains ATF2-Jun and IRF3 recognition sequences that 
are separated by a longer distance than those in the interferon-β enhancer.  Cells that co-
expressed IRF3 with different ATF2 and Jun variants produced different levels of 
RANTES transcripts [Fig. 4.3, left panel].  The amino acid substitutions in ATF2 and Jun 
had similar effects on the level of RANTES transcripts as they had on the levels of 
interferon-β and LEPREL1-T1 transcripts.  These amino acid substitutions also had 
similar, albeit smaller, effects on the level of RANTES transcripts when ATF2 and Jun 
were expressed in the absence of IRF3 [Fig. 4.3, left panel]. 
 We also investigated the effects of the amino acid substitutions in ATF2 and Jun 
on transcription of genes that contained ATF2-Jun recognition sequences, but no known 
IRF3 recognition sequences.  IRF3 expression alone or in combination with the ATF2 
and Jun variants had little effect on the levels of UPA or TPA transcripts, consistent with 
the absence of known IRF3 recognition sequences in these genes.  The amino acid 
substitutions in ATF2 and Jun that altered the intrinsic orientation preference of 
heterodimer binding at IFNb (ATF2-JunXG versus ATF2XG-Jun) affected the levels of 
UPA and TPA transcripts both in the absence and in the presence of IRF3 (Fig. 4.3, left 
panel).  These ATF2 and Jun variants had opposite effects on the levels of UPA and TPA 
transcripts compared to their effects on the levels of interferon-β, LEPREL1-T1 and 
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RANTES transcripts in the presence of IRF3.  The amino acid substitutions in ATF2 and 
Jun that altered the orientation of heterodimer binding at IFNb mainly in the presence of 
IRF3 (ATF2XD-JunXK and ATF2XK-JunXD) had small effects on the levels of UPA 
and TPA transcripts in the absence and presence of IRF3.  Taken together, the results of 
these experiments demonstrate that the amino acid substitutions in ATF2 and Jun that 
affected the orientation of heterodimer binding at IFNb in vitro had distinct effects on 
transcription of different endogenous genes.   
 
II.D.  Effects of ATF2-Jun substitutions under different conditions 
 
 
 We investigated if the amounts of the ectopic ATF2 and Jun variants expressed in 
cells affected the levels of the endogenous transcripts.  The levels of endogenous ATF2 
and Jun proteins were undetectable compared with ectopic ATF2 and Jun variants (Fig. 
4.4), yet ectopic ATF2 and Jun expression generally did not significantly increase the 
levels of endogenous gene transcripts.  The relative amounts of different ATF2 and Jun 
protein variants varied between different experiments [Fig 4.4] and the levels of 
endogenous transcripts did not correlate with the differences in the amounts of the ATF2 
and Jun variants expressed.   The amounts of ATF2 and Jun in HeLa cells were therefore 
not limiting for transcription of the endogenous genes examined, which is consistent with 
a past report (1).   It is therefore likely that the differences in the levels of the endogeous 
transcripts observed in cells that expressed different combinations of ATF2 and Jun 
variants were caused by displacement of endogenous ATF2 and Jun by the ectopically 
expressed ATF2 and Jun variants. 
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Fig. 4.4. Protein expression of different ATF2 and Jun variants did not influence the expression of 
IRF3.  (A) Western analyses of ATF2 expression levels in HeLa cells transfected with IRF3 together with 
different combinations of ATF2 and Jun variants. (B) Western analyses of Jun expression in same samples. 
(C) Western analyses of IRF3 expression in the same samples.  Lane 1: IRF3; lane 2: ATF2, Jun, and IRF3; 
lane 3: ATF2XG, Jun, IRF3; lane 4: ATF2, JunXG, IRF3; lane 5: ATF2XD, JunXK, IRF3; lane 6: 
ATF2XK, JunXD, IRF3.  1.5 μg of each plasmid was transfected for all samples.  Lane 1 contained 3 μg of 
pcDNA. 
 
 
We investigated if the relative amounts of the ectopic ATF2 and Jun variants 
expressed in cells affected the levels of the endogenous transcripts.  We varied the 
relative amounts of ectopic ATF2 to Jun variants in cells by transfecting different ratios 
of plasmids encoding the ATF2 versus Jun variants.  The levels of ectopic ATF2 and Jun 
transcripts varied 10 to 5-fold, respectively among in cells transfected with different 
concentrations of the plasmids [Fig. 4.5, left panel].  By comparison, the relative levels of 
transcripts encoding ATF2 or Jun variants that favored opposite orientations of 
heterodimer binding (ATF2 vs. ATF2XG, Jun vs. JunXG, ATF2XD vs. ATF2XK, 
JunXD vs. JunXK) varied less than 15% on average when equivalent amounts of 
plasmids encoding these variants were transfected and did not correlate with the relative 
levels of IFN-b transcripts [Fig. 4.5, right panel].  The amino acid substitutions in ATF2  
and Jun had consistent effects on the level of interferon-β transcripts when different 
ratios of the plasmids encoding the ATF2 and Jun variants were transfected into cells [Fig. 
4.3, right panel].     
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 Fig. 4.5.  Different ratios of transfected ATF2-to-Jun plasmid produce different amounts of IFN-b 
and ectopic ATF2, Jun, and IRF3 transcripts.  (A) qRT-PCR detection of (i) IFN-b and plasmid-derived 
(ii) ATF2, (iii) Jun, and (iv) IRF3 transcripts in cells co-transfected with 1.5 μg of IRF3 together with 
either 0, 0.5, 1, 1.5, 2, 2.5, or 3 μg and Jun and either 3, 2.5, 2, 1.5, 1, 0.5, or 0 μg of ATF2, respectively.  
(B) For the same experiment, the levels of (i) IFN-b, (ii) ATF2, (iii) Jun, and (iv) IRF3 transcripts were 
compared between samples transfected with the same ratio of ATF2 to Jun plasmid (from left to right 5:1, 
3:1, 1:1, 1:3, 1:5) but differed in their amino acid substitutions as indicated the upper right figure legend.  
All samples were digested with DNase I, and the addition of cDNA from reactions lacking reverse 
transcriptase did not result in qRT-PCR amplification (data not shown), indicating that this analysis did not 
detect plasmid DNA. 
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Despite consistency in relative levels of interferon-β transcripts in cells 
transfected with the same ratio of ATF2 to Jun plasmid, the absolute levels of interferon-
β transcripts varied between cells transfected with different ratios of the plasmids [Fig 4.5, 
left panel].   Specifically, transcription of genes regulated by IRF3 (interferon-β, 
RANTES, LEPREL-T1) was reduced in cells transfected with higher ratios of plasmids 
encoding Jun relative to ATF2 variants [Figs 4.3, right panel].  In contrast, transcription 
of genes that were not regulated by IRF3 (TPA, UPA) was not reduced under these 
conditions.  This selective reduction in transcription of genes regulated by IRF3 
correlated with a reduction in the level of IRF3 expression in cells transfected with higher  
ratios of plasmids encoding Jun relative to ATF2 variants [Fig. 4.5, left panel].  This 
reduction is likely due to the higher absolute level of ectopic Jun expression compared to 
ectopic ATF2 expression [Fig 4.6, right panel].  Nonetheless, the reduction in 
transcription of genes regulated by IRF3 in cells transfected with higher ratios of 
plasmids encoding Jun relative to ATF2 variants did not alter, and is likely to be 
unrelated to, the effects of the amino acid substitutions in ATF2 and Jun on endogenous 
gene transcription.   
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Fig. 4.6.  Comparison of the relative expression levels of JUN-atf2 versus ATF2-jun and Jun versus 
ATF2 ectopic proteins.  (A) Western analyses of cells transfected with 4.5 μg of ATF2-jun (AJ) chimera-
encoding plasmid and (from left to right) 80 ng, 140 ng, 200 ng, 260 ng, 320 ng, 380 ng, 440 ng, or 500 ng 
of JUN-atf2 (JA) chimera-encoding plasmid.  The left-most lane is untransfected cells. The two right-most 
lanes are cells expressing protein from (from left to right) 1.5 μg and 4.5 μg of ATF2-encoding plasmid, 
which is recognized by both ATF2 antibodies.  (B) Western analyses of cells transfected with 4.5 μg of 
ATF2-encoding plasmid and (from left to right) 40 ng, 70 ng, 100 ng, 130 ng, 160 ng, 190 ng, 220 ng, or 
250ng of Jun-encoding plasmid.  The left-most lane is untransfected cells.  The two right-most lanes are 
cells expressing protein from (from left to right) 250 ng and 500 ng of JUN-atf2 chimera-encoding plasmid, 
which is recognized by ATF2 and Jun antibodies.  The expression level of JUN-atf2 chimeric protein in 
cells transfected with 250 ng plasmid is approximately two-fold higher than ATF2 expression in cells 
transfected with 4.5 μg of ATF2 and is approximately equivalent to Jun expression in cells transfected with 
40 ng of Jun.  Therefore, expression of ectopic Jun is approximately 56-fold greater than ectopic ATF2 
(2250 / 40 = 56.25). 
 
 
II.E.  Regions of ATF2-Jun that mediate effects on transcription 
 
 
We investigated if the amino acid substitutions in ATF2 and Jun that determined 
the intrinsic orientation of heterodimer binding at IFNb affected transcription of different 
genes through similar or distinct mechanisms.  To this end, we compared the regions of 
ATF2 and Jun that determined the effects of XG heterodimer substitutions at different 
genes by using chimeric proteins in which the amino- and carboxyl-terminal regions of 
ATF2 and Jun were exchanged [JUN-atf2, ATF2-jun Fig. 4.7].  JUN-atf2 proteins were 
expressed at levels that were about 100-fold higher than those of the ATF2-jun variants 
when equal amounts of the plasmids were transfected into cells [Fig. 4.6, left panel].  
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Fig. 4.7. Maps of ATF2, Jun, JUN-atf2, and ATF2-jun proteins.   Full-length ATF2 (orange) and Jun 
(teal) proteins are shown divided into amino- and carboxy-terminal domains.  The start of the carboxy-
terminal domain coincided with the start of bZIP domain.   The amino- and carboxy-terminal domains of 
ATF2 and Jun were swapped to produce JUN-atf2 and ATF2-jun chimeric proteins, as indicated in the 
bottom two maps.   The relative sizes of the amino- and carboxy-terminal domains of ATF2 and Jun are 
drawn to proportion. 
 
 
We compensated for this difference between the efficiencies of ectopic JUN-atf2 
versus ATF2-jun and for ectopic Jun versus ATF2 [Fig. 4.6, right panel] expression by 
transfecting higher ratios of the plasmids encoding ATF2-jun or ATF2 variants relative to 
plasmids encoding JUN-atf2 or Jun variants, respectively.  Under these conditions, the 
amino acid substitutions in ATF2 and Jun had consistent effects on the levels of IFN-b, 
LEPREL1-T1, RANTES, TPA, and UPA transcripts.  The consistent effects of the amino 
acid substitutions in ATF2 and Jun on endogenous gene transcription under the wide 
range of conditions examined suggest that the same protein complexes were assembled at 
the endogenous regulatory elements regardless of the relative amounts of the ATF2 and 
Jun variants expressed in the cells.   
 At the interferon-β and LEPREL1-T1 genes, the amino acid substitutions that 
affected heterodimer orientation had the same effects on the activities of the chimeric 
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proteins that contained the same bZIP and carboxyl-terminal regions as they had on non-
chimeric ATF2 and Jun [Fig. 4.8].  Cells in which the chimeric protein containing the 
bZIP and carboxyl-terminal regions of Jun was predicted to bind to the right IFNb half-
site (Jun:ATF2-ATF2:JunXG) produced higher levels of interferon-β and LEPREL1-T1 
transcripts than cells in which the chimeric protein containing the bZIP and carboxyl-
terminal regions of ATF2 was predicted to bind to the right IFNb half-site 
(Jun:ATF2XG-ATF2:Jun) [Fig. 4.8]. These results indicate that the bZIP and carboxyl-
terminal regions of ATF2 and Jun determined the effects of the orientation of 
heterodimer binding on transcription of the interferon-β and LEPREL1-T1 genes.  
 At the RANTES, TPA and UPA genes, the amino acid substitutions that affected 
intrinsic heterodimer orientation had the opposite relative effects on the activities of the 
chimeric proteins that contained the carboxy-terminal regions of ATF2 and Jun as they 
had on non-chimeric ATF2 and Jun [Fig. 4.8]. Cells in which the chimeric protein 
containing the carboxy-terminal region of Jun was predicted to bind to the right half-site 
at IFNb (JUN-atf2-ATF2-junXG) produced lower levels of RANTES, TPA and UPA 
transcripts than cells in which the chimeric protein containing carboxy-terminal region of 
ATF2 was predicted to bind to the right half-site at IFNb (JUN-atf2XG-ATF2-jun) [Fig. 
4.8].  Taken together, these results indicate that different regions of ATF2 and Jun 
determined the effects of the orientation of heterodimer binding on transcription of 
different genes. 
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 Fig. 4.8.  Effects of XG substitutions in non-chimeric versus chimeric ATF2 and Jun proteins on 
transcription of endogenous genes using different plasmid ratios.  (A) Levels of  IFN-b, LEPREL1-TT1, 
RANTES, UPA and TPA transcripts were measured in cells transfected with different ratios (from left to 
right: 120:1, 60:1, 30:1, 14:1, or 9:1) of either ATF2 to JunXG (green) or ATF2XG-to-Jun (red). B) Levels 
of IFN-b, LEPREL1-T1, RANTES, UPA, and TPA transcripts were measured in cells transfected with 
different ratios (from left to right: 1:18, 1:30, 1:45, 1:90, 1:180) of either JUN-atf2 to ATF2-junXG (blue) 
or JUN-atf2XG to ATF2-jun (yellow).  The data show the mean from two qPCR reactions and are 
representative of at least two independent transfection experiments. 
 108
III.  SUMMARY AND CONCLUSIONS 
 
 
The interferon-β enhancer is one of the few transcription regulatory complexes 
for which both the atomic-resolution structure as well as the functional synergy among 
the transcription factors have been analyzed (3, 5, 6, 12, 15-17, 22, 24).  These data have 
been interpreted to show that cooperative binding by a unique configuration of regulatory 
proteins mediates synergistic activation of interferon-β reporter genes.      
The discovery that ATF2-Jun heterodimers can bind the interferon-β enhancer in 
both orientations in association with iIRF3 and HMGI raised the question whether the 
orientation of heterodimer binding affects transcriptional activity.  Our results 
demonstrate that two different combinations of amino acid substitutions in ATF2 and Jun 
produced opposite orientations of heterodimer binding produced corresponding changes 
in transcription of the endogenous interferon-β gene.  These results suggest that opposite 
orientations of ATF2-Jun heterodimer binding at the interferon-β enhancer resulted in 
different levels of interferon-β transcription.  Moreover, these data indicate that the same 
interactions with DNA and with iIRF3 mediate ATF2-Jun association with the interferon-
β enhancer in vitro and in cells.   
The effects of the amino acid substitutions that reverse the orientation of ATF2-
Jun heterodimer binding on transcriptional activity could be mediated by several different 
mechanisms.  The amino acid substitutions had consistent effects on transcriptional 
activity when different relative amounts of ATF2 and Jun were expressed.  It is therefore 
unlikely that the effects were due to changes in the relative amounts of different ATF2 or 
Jun dimers in the cells.  Heterodimers in which Jun favored the right half-site had a 
significantly greater affinity for IFNb compared with heterodimers in which ATF2 
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favored the right half-site in the presence of either iIRF3 or HMGI , which is consistent 
with the intrinsic orientation preference of ATF2-Jun heterodimers at IFNb in the absence 
or presence of iIRF3.  Therefore, it is possible the effects of substitutions in ATF2 and 
Jun are mediated by differences in the stability of ATF2-Jun-iIRF3 complex formation at 
IFNb.  Consistent with this, regions of ATF2 and Jun which mediated the effects of 
amino acid substitutions on the expression of interferon-β contained the DNA-binding 
domains of ATF2 and Jun.  Consistent with the idea that the formation of ATF2-Jun-
IRF3 complexes is a limiting factor in the transcription of interferon-b, monoallelic IFN-
β expression occurs in HeLa cells six hours after infection (1).  Therefore, ectopic ATF2-
Jun-IRF3 complexes have the potential activate five to six other interferon-β loci that 
would otherwise be silent.          
Amino acid substitutions in ATF2 and Jun that affected heterodimer orientation 
had distinct effects on transcription of several endogenous genes.  Among the genes 
investigated, the amino acid substitutions in ATF2 and Jun had qualitatively similar 
effects at genes that contained composite ATF2-Jun as well as IRF3 recognition 
sequences, but different relative effects at genes that did not contain composite sites.  
These results suggest that the effects of heterodimer orientation on transcriptional activity 
depend on the sequences of the enhancer and/or promoter regions.  The qualitatively 
similar effects of the amino acid substitutions on transcription of the interferon-b and 
LEPREL1-T1 genes are consistent with the interpretation that the local sequences 
encompassing the enhancer regions are more important than the distance from the 
promoter region or the nature of the core promoter in determining the effect of the 
orientation of ATF2-Jun binding on transcriptional activity.     
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 The amino acid substitutions in ATF2 and Jun that alter contacts to the 
asymmetric central based pair (ATF2XG and JunXG) were predicted to influence the 
orientation of heterodimer binding at all of the genes investigated.  The effects of these 
substitutions on transcription of different genes indicate that ATF2-Jun heterodimer 
orientation is likely to affect transcription of many endogenous genes, and that the 
orientation that produces optimal activation differs among these genes.  
The amino acid substitutions in ATF2 and Jun that affected contacts with IRF3 
(ATF2XD, ATF2XK, JunXD, JunXK) were predicted to alter heterodimer orientation 
specifically at genes containing composite ATF2-Jun-IRF3 recognition sequences.  
Unexpectedly, these substitutions had opposite effects on transcription of several genes 
that are not known to contain IRF3 recognition sequences and that were not affected by 
IRF3 expression.  The mechanisms whereby these substitutions affected transcription of 
these endogenous genes remain unknown, and could reflect the effects of these 
substitutions on interactions with the DNA or orientation-dependent contacts with other 
interaction partners.  Consistent with the former interpretation, we found that XD and XK 
substitutions had opposite effects on the orientation preferences of ATF2-Jun 
heterodimers in the absence of IRF3 in vitro. 
The amino- and carboxyl-terminal regions of ATF2 and Jun had distinct effects 
on the heterodimer orientation that produced the higher level of transcription at different 
genes.  At the interferon-β and LEPREL1-T1 genes, the carboxyl-terminal regions of 
ATF2 and Jun had a dominant effect on the orientation of heterodimer binding that 
produced a higher level of transcription.  This result is consistent with roles of 
orientation-dependent interactions between the bZIP domains or carboxyl-terminal 
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regions of ATF2 and/or Jun with IRF3 in transcription activation.  Consistent with this, 
these interactions affected the affinity IRF3 binding to the IFNb in the absence of HMGI 
in vitro.  Conversely, the amino-terminal regions of ATF2 and Jun had a dominant effect 
on the orientation-dependence of transcription activation at the RANTES, UPA and TPA 
genes.  Thus, there appear to exist multiple molecular mechanisms that mediate the effect 
of the orientation of ATF2-Jun heterodimer binding on transcription of different genes. 
 
 
IV.  MATERIALS AND METHODS 
 
 
IV.A.  Generation of ATF2-Jun orientation isomers 
 
 
 Past analyses of the functional effects of heterodimer orientation in transcription 
have utilized alterations in DNA sequences to control the orientation of heterodimer 
binding (2, 18) .  A downside of this strategy is that it necessitates the use of reporter 
plasmids rather than assaying the effects on chromatinized templates.  Another 
disadvantage of this strategy is that the changes in the DNA sequence that influence the 
preferred orientation of heterodimer binding could also influence the binding affinity of 
the heterodimer as well as proteins that bind to overlapping sequences.  Therefore, using 
my understanding of heterodimer-DNA contacts required for bATF2-bJun binding to 
IFNb as well as amino acid contacts required for cooperative DNA-binding interactions 
between bATF2-bJun and iIRF3, I have designed mutationally-trapped orientation 
isomers of bATF2-bJun heterodimers.  These orientation isomers allow manipulation of 
the preferred orientation of heterodimer binding in independent ways at endogenous 
genomic loci.   
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 Heterodimers in which bJun preferred the right PRDIV half-site contained alanine 
substitutions at either R270 in Jun (ATF2-JunXG) or alanine substitutions at E331, D332, 
D334, E335 in ATF2 and R263 in Jun (ATF2XK-JunXD).   Heterodimers in which ATF2 
preferred the right PRDIV half-site contained alanine substitutions at either R352 in 
ATF2 (ATF2XG-Jun) or alanine substitutions at D246, E248, E251 in Jun and R345A in 
bATF2 (ATF2XD-JunXK).   
 
IV.B.  Over-expression of exogenous protein in HeLa cells 
 
 
 Full-length ATF2, Jun, and IRF3 human open reading frames were cloned into 
pcDNA3.1+ (Invitrogen) eukaryotic expression plasmids.  All plasmids were purified in 
parallel using EndoFree plasmid maxi kit (Qiagen, Valencia, CA) to avoid potential toxic 
side-effects on cells following transfection with high amounts of plasmid. HeLa cells 
were seeded at a concentration of ~200,000 cells per well in a 6-well plate.  18 hours after 
plating, cells were transfected with untagged plasmids purified using Endo-Free plasmid 
purification kit (Stratagene) using FuGENE6(μl) (Roche, Nutley, NJ) :DNA(μg) ratio of 
1.5 : 1.    
 
IV.C.  Measurement of endogenous gene expression 
 
 
 15-18 hours after transfection cells were washed twice with PBS and infected 
with 200 hemagluttanin units of Sendai virus per ml.   Six hours after infection, cells 
were harvested and total mRNA was isolated and treated with RNase-free DNAase using 
RNeasy RNA purification kit (Strategene) following the manufacturer’s protocol.  1μg of 
total RNA was used to synthesize cDNA using Transcriptor first strand synthesis kit 
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(Roche).  Amplification primers for interferon-β, LEPREL1-T1, RANTES, UPA, and 
TPA gene transcriptions were designed at https://www.roche-applied-
science.com/sis/rtpcr/upl/index.jsp?id=UP030000 and synthesized by Integrated DNA 
Technologies, Inc. (Coralville, IA) and added to cDNA samples.  The amount of 
amplified product was quantified using the LightCycler480 system (Roche, Nutley, NJ). 
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CHAPTER 5: SUMMARY, IMPACT, AND OUTLOOK 
 
 
I.  SUMMARY 
 
 
 Transcription initiation is controlled by multi-protein transcription factor 
complexes assembled at regulatory elements and at the site of transcription initiation.  
Two types of models have been proposed to explain how multiple proteins function in 
concert to regulate transcription.  According to “jigsaw puzzle” type models, the 
transcription factors must assemble in a specific configuration to function.  According to 
“independent agents” type models, the configuration of the transcription factors is not 
essential for function.   
 The difference between these two types of models reflects different assumptions 
concerning the influence of steric constraints on the multivalent interactions among 
proteins and nucleic acids that regulate transcription.  Interactions among proteins that 
bind to closely juxtaposed sequences (composite regulatory elements) are generally 
thought to require a specific arrangement of the transcription factors at regulatory 
elements.  Conversely, interactions between proteins that bind to distal enhancers and 
proteins that bind to the core promoter, are predicted not to require a specific 
arrangement of the proteins on the DNA.  
 The interferon-β enhancer has been investigated as a model for synergistic 
transcription activation by proteins that bind to closely juxtaposed sequences (7, 9, 14, 15, 
19, 37, 41, 44, 45).  The structural nature of complexes at the interferon-β enhancer has 
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been investigated using several different experimental approaches.  Photo-crosslinking 
experiments indicate that the orientation of ATF2-Jun heterodimers binding is fixed upon 
IRF3 binding such that ATF2 contacts the half-site proximal to IRF3 (9).  In contrast, the 
X-ray crystal structure of the minimal DNA binding domains of ATF2, Jun and IRF3 
shows the opposite orientation of ATF2-Jun heterodimer binding in which Jun contacts 
the half-site proximal to IRF3 (23).  The results from each of these studies were 
interpreted to indicate that ATF2-Jun heterodimers interact with IRF3 in a fixed, albeit 
opposite, orientation.  
 We investigated the effects of interactions with IRF3 and HMGI on the 
orientation of ATF2-Jun heterodimer binding at the interferon-β enhancer and the effects 
of heterodimer orientation on the cooperativity of complex formation in vitro and on 
endogenous interferon-β gene transcription in cells.  IRF3 and HMGI bound 
cooperatively with both orientations of ATF2-Jun heterodimers at the interferon-β 
enhancer.   Cooperative DNA binding by both ATF2-Jun heterodimer orientations with 
IRF3 was mediated at least in part by interactions between charged residues in IRF3 and 
symmetry-related residues in both subunits of the heterodimer.  
 Mutations in ATF2 and Jun that caused opposite orientations of heterodimer 
binding in vitro also resulted in distinct levels of endogenous interferon-β gene 
transcription.  Different regions of ATF2 and Jun determined the effects of heterodimer 
orientation on transcription of different endogenous genes. The orientation of 
heterodimer binding therefore has gene-specific effects on transcription that are mediated 
by distinct mechanisms.   
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I.A.  Cooperative DNA-binding by ATF2-Jun and IRF3 
 
 
 I have applied gelFRET analysis (25) to the examination of the orientation of 
binding by ATF2-Jun heterodimers at the interferon-β enhancer.  This revealed a 
previously unobserved conformational heterogeneity within ATF2-Jun-IRF3-DNA 
complexes, where iIRF3 interacts equivalently with both bATF2-bJun binding 
orientations.   Although bATF2-bJun has a significant preference for the orientation in 
which bJun binds to the right IFNb half-site, bATF2-bJun can also bind to IFNb in the 
opposite orientation.  The relative preferences for these two orientations are precisely 
conserved in the presence of the DNA-binding domain of iIRF3, indicating that iIRF3 
can interact equivalently with either orientation of bATF2-bJun binding at IFNb.    
Moreover, in the presence of iIRF3 together with HMGI, bATF2-bJun binds to IFNb 
with no orientation preference [Fig 5.1].  This can be indicative of either asymmetric 
interactions between bATF2-bJun and HMGI or asymmetric interactions between 
bATF2-bJun and iIRF3 in the presence of HMGI.   
 The previous model of cooperativity between ATF2-Jun and IRF3 derived from 
x-ray crystallographic analysis evokes indirect, DNA-mediated interactions between 
ATF2-Jun and IRF3 in which complementary protein-induced changes in the DNA 
structure promotes more favorable DNA-binding (23).  Our model of cooperativity 
between bATF2-bJun and iIRF3 includes a heterodimer-iIRF3 contact previously 
observed in the crystal structure as well as additional heterodimer-iIRF3 interactions that 
involve regions of bATF2 and bJun not included in the crystal structure.  Due to the 
redundant nature of the heterodimer-iIRF3 interactions, previous methods for the 
analyses of the role of residues in individual subunits on cooperative interactions between 
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bATF2-bJun and iIRF3 were not possible.        
 By analyzing the reciprocal effects of mutations in bATF2 versus bJun on DNA-
binding in the presence of iIRF3, I was able to detect competing alternative interactions 
between iIRF3 and conserved amino acid charges in bATF2 and bJun.   Moreover, the 
relative effects of mutations in bATF2 versus bJun on heterodimer orientation preference 
were qualitatively similar in the presence of HMGI, indicating that HMGI does not 
influence the nature of the interaction between bATF2-bJun and iIRF3. Therefore, 
depending on the charged state of ATF2 and Jun, the heterodimer can adopt different 
binding orientation preferences in higher order interferon-β enhancer complexes 
containing IRF3 and HMGI. 
 Substitutions in bATF2-bJun that forced interactions between either bATF2 and 
iIRF3 in the left half-site or bJun and iIRF3 in the right half-site were slightly more 
potent than substitutions that forced interactions between iIRF3 and the opposite 
orientation of heterodimer binding.   Cooperative DNA-bending interactions between 
ATF2-Jun and IRF3 have previously been hypothesized to promote the orientation where 
ATF2 binds to the left half-site and Jun binds to the right half-site.  Therefore, it is 
possible that indirect interactions of this nature may add an asymmetric component to the 
interactions between bATF2-bJun and iIRF3.  Alternatively, the intrinsic orientation 
preference of heterodimers for the orientation where bJun binds to the right half-site, may 
also contribute to the incomplete re-orientation of heterodimers that are deficient in direct 
interactions with iIRF3.  Whatever the underlying cause of orientation dependent stability 
of the complex, this is an important aspect of the bATF2-bJun-iIRF3 complex formation 
at the interferon-β enhancer.  The interplay between asymmetric interactions and amino 
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acid interactions between the heterodimer and iIRF3 that allow the heterodimer to bind in 
either orientation could potentially permit the modulation of the stability of the 
complexes at the same enhancer site through charge modifications in ATF2 and Jun.  
 
 
 
 
 
Figure 5.1 Model for the role of charged amino acid residues in the configuration of IFNb 
complexes containing bATF2-bJun, iIRF3, and HMGI.  Upper diagram: bATF2-bJun heterodimers 
have an intrinsic orientation preference at IFNb (yellow) where bJun (cyan) favors the right IFNb half-
site and bATF2 (orange) favors the left IFNb half-site.  Middle diagram: Negatively charged amino 
acid residues N-terminal to the bZIP basic region (indicated by negative signs) and an arginine 
(indicated by plus sign) in the bZIP basic region are conserved in bATF2 and bJun.  This allows 
equivalent interactions with D45 (indicated by negative sign) and K70 (indicated by plus sign) of iIRF3 
(light green circle) regardless of the orientation of DNA-binding by bATF2-bJun.  Lower diagram:
Interactions between bATF2-bJun and iIRF3 are preserved in the presence of an unknown number of 
HMGI molecules (dotted purple circle).  Indirect or direct interactions between HMGI and bATF2-bJun 
eliminate the orientation preference of bATF2-bJun binding at IFNb. 
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I.B.  Role of ATF2-Jun orientation in interferon-β transcription 
 
 
 The functional significance of the structural organization of transcription 
regulatory complexes has been investigated mainly using artificial reporter genes (5, 9, 
10, 15, 24, 37, 39). Chimeric proteins that contain the DNA binding domain of one 
protein fused to a regulatory region from another protein can regulate reporter gene 
transcription. This fact has been interpreted to indicate that the architecture of the 
transcription complex is not important for transcription regulation; however, artificial 
reporter genes are unlikely to adopt the same chromatin structure and transcription factor 
configuration as endogenous genes.   
 The role of heterodimeric transcription factor orientation in native gene 
transcription has not been determined.  In order to elucidate the functional role(s) of 
ATF2-Jun orientation at the endogenous interferon-β gene, I have used my structural 
understanding of ATF2-Jun-IRF3-DNA complexes to design mutationally-trapped 
ATF2-Jun orientation isomers in which specific alanine substitutions permit favorable 
interactions between ATF2-Jun and IRF3 only when ATF2-Jun is bound to DNA in 
either one or the other orientation.  Using these oriented complexes, I first wanted to 
know whether the orientation of heterodimer binding influences the stability of enhancer 
complexes in vitro.          
 GelFRET analysis showed that wild-type ATF2-Jun heterodimers bound to the 
interferon-β enhancer element have a significant preference for the orientation in which 
Jun binds to the right DNA half-site.  Therefore, amino acid substituted heterodimers 
which differ in the direction that the heterodimer is forced to interact with the DNA 
should also differentially affect the formation of heterodimer-DNA complexes.   To test 
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this, I compared the effect of increasing concentrations of iIRF3 on the formation of 
complexes containing oppositely oriented bATF2-bJun heterodimers and found that 
heterodimers in which bJun favors the right IFNb half-site produce significantly more 
complexes over a range of iIRF3 concentrations.   
 If asymmetric heterodimer-DNA interactions do in fact differentially affect the 
stability of DNA binding by oppositely oriented heterodimers, I hypothesized that 
interactions with HMGI which eliminate bias in the orientation of wild-type ATF2-Jun 
heterodimers should also eliminate differences in the stability of DNA-binding by 
oppositely oriented heterodimers.  Consistent with this, I found that when titrating 
oppositely oriented heterodimer-HMGI complexes with increasing amounts of iIRF3 or, 
conversely, when titrating heterodimer-iIRF3 complexes with increasing amounts of 
HMGI, equal amounts of complexes are formed.   Thus, iIRF3 and HMGI cooperatively 
reduce the effect of heterodimer orientation of the stability of complex formation at IFNb, 
consistent with their cooperative reduction in the orientation preference of ATF2-Jun 
heterodimers. 
The discovery that ATF2-Jun heterodimers can bind the interferon-β enhancer in 
both orientations equally well in association with iIRF3 and HMGI raised the question of 
whether a particular orientation of heterodimer binding is actually required for 
functionally active enhancer complexes.  To address this question, I measured the virus-
induced activation of endogenous interferon-β transcript levels in HeLa cells co-over-
expressing full-length IRF3 and full-length ATF2 and Jun that contained the amino acid 
substitutions predicted to alter heterodimer orientation.   In the absence or presence of 
exogenous IRF3, I saw reproducible differences between cells expressing different 
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heterodimer variants, where heterodimers that strongly favor the orientation in which Jun 
binds to the right have higher levels of interferon-β transcripts.   
 When comparing the in vitro binding results to the in vivo results, I saw that the 
heterodimer orientation which produces higher levels of interferon-β transcripts in vivo 
also has a relatively greater stability of DNA binding.  Therefore, I hypothesized that the 
effect of binding orientation on transcription could is mediated by differences in the 
amount of ATF2-Jun-IRF3 complexes formed in HeLa cells in a manner potentially not 
even related to differences stereo-specific architecture of the complexes.  In order to 
distinguish between the effects of heterodimer orientation on DNA-binding affinity 
versus trans-activation, I divided ATF2 and Jun into two regions: an amino-terminal 
region that contained the trans-activation domain and a carboxy-terminal region that 
contained the DNA-binding domain; and constructed chimeric proteins, abbreviated as 
AJ or JA, in which the amino- and carboxy-terminal regions of ATF2 and Jun were 
exchanged. 
It was predicted that, for genes regulated by the stability of heterodimer binding to 
DNA, the C-terminal regions of ATF2 and Jun should be sufficient to mediate the effects 
of heterodimer orientation on endogenous gene transcript levels regardless of whether the 
activation domains are switched.  On the other hand, for genes that are regulated 
primarily by stereo-specific interactions between the heterodimer trans-activation 
domains and other regulatory proteins, exchange of the N-terminal regions of ATF2 and 
Jun should reverse the effects of heterodimer orientation on gene transcript levels.  I 
found that reversal of the entire N-terminal regions of XG-substituted heterodimers did 
influence the relative effects of XG substitution in ATF2 versus Jun on interferon-β and 
 124
LEPREL1-T1 transcript levels over a range of JA and AJ plasmid ratios.  In contrast, 
exchange of the N-terminal regions of ATF2 and Jun reversed the relative effects of XG 
substitution in ATF2 versus Jun on RANTES, TPA, and UPA genes over a range of 
plasmid ratios.           
 Taken together, these results indicate that the regions of ATF2 and Jun that 
contain the trans-activation domain mediate the effect of heterodimer orientation on the 
efficiency on several endogenous genes including RANTES, TPA, and UPA, consistent 
with previously reported role of activation domain positioning in mediating the effects of 
Fos-Jun orientation on reporter gene activation.  In contrast, for genes such as interferon-
β and LEPREL1-T1, that contain a composite ATF2-Jun-IRF3-HMGI site, regions of 
ATF2 and Jun which contain the DNA-binding domain primarily determines the effects 
of heterodimer orientation on gene activation [Fig 5.2]. 
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Figure 5.2 Model for role of ATF2-Jun orientation in the transcription of different genes.  Cells 
expressing heterodimers with substitutions that force ATF2 (orange) to the left IFNb half-site and Jun 
(cyan) to the right IFNb half-site produce more interferon-β (IFNB) as well as LEPREL1-T1 transcripts 
(indicated by double-headed arrows).  Exchange of the N-terminal domains of ATF2 and Jun (bottom 
domain) does not influence the effects of these substitutions on transcription.  The effects of orientation 
on IFNB and LEPREL1-T1 transcription are therefore mediating by the DNA-binding activity of 
ATF2-Jun (indicated by curved arrow).  In contrast, exchange of the N-terminal domains of ATF2 and 
Jun reverses the relative effect of heterodimer orientation on expression of RANTES, TPA, and UPA. 
The effect of orientation on RANTES, TPA, and UPA transcription is therefore mediated by the trans-
activation activity of ATF2-Jun (indicated by curved arrow).  
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II.  IMPACT 
 
 
 Cells must generate complex developmental programs and responses to their 
environments, which are largely encoded by different combinations of transcription 
factors that have a synergistic or “greater-than-additive” effect on gene expression.  This 
process certifies that no specific transcription factor alone, which has the capacity to 
recognize hundreds of gene regulatory loci, will erroneously activate the expression of 
inappropriate genes.  Therefore, understanding how groups of transcription factors work 
together to achieve gene activation is important for understanding the underlying 
principles of cellular regulation.  Many mechanisms for transcriptional synergy have been 
proposed, but few have been critically tested.  With this dissertation research, I have 
begun to paint a clearer picture of both the structural basis and the functional significance 
of synergistic interactions within transcription factor complexes.   
 
II.A.  Comparison with other ternary complexes 
 
 
 Comparison of cooperative complex formation by Fos-Jun-NFAT and ATF2-Jun-
IRF3 reveal distinct mechanisms of cooperativity between these transcription factor 
complexes.  Whereas asymmetric heterodimer-DNA contacts together with asymmetric 
Fos-Jun and NFAT interactions modulate the stability of Fos-Jun-NFAT complex 
formation at different nonconcensus DNA sites (24), asymmetric heterodimer-IRF3 
contacts in complexes that contain different charge modification together with 
asymmetric ATF2-Jun-DNA interaction modulate the stability of ATF2-Jun-IRF3 
complex formation at the same DNA site. 
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 The structures of many transcription factors vary at different binding sites  (6, 16, 
21, 24, 28, 31, 33, 36, 38).  These differences in structure are thought to contribute to the 
differences in the effects of these factors on transcription of different genes  (1, 6, 11, 21, 
32, 34, 38).  In the case of nuclear hormone receptors, the spacing and the relative 
orientations of multiple recognition sequences can influence the transcriptional activity of 
the complex(1, 6, 11, 21, 32, 34).  Our results demonstrate that ATF2-Jun, IRF3 and 
HMGI can bind to one recognition sequence in different configurations.      
 This discovery demonstrates that transcription factor complexes consisting of 
multiple proteins can adopt more than one configuration at a single regulatory element.  
We also found that the bATF2-bJun-iIRF3-HMGI complex has a half-life shorter than 30 
seconds in the presence of an excess of competitor oligonucleotide.  Different 
configurations of this complex are therefore in dynamic exchange, at least in vitro.  Some 
of the residues that influence the configurations of the complex can be modified (13, 22).  
It is therefore possible that the balance between alternative configurations of bATF2-
bJun-iIRF3-HMGI binding is regulated by post-translational modifications or by 
interactions with additional proteins. 
 
 
II.B.  Implications in gene regulatory specificity 
 
 
 This and the previously described gelFRET analyses were utilized in concert to 
illustrate how subtle charge modifications in ATF2 and Jun can dramatically affect a 
balance between two alternative interactions between ATF2-Jun and IRF3 at sites of 
active gene transcription.  Post-translational modification of transcription factors occurs 
frequently (18, 35), and is a potential means by which the cell can control the orientation 
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preference of heterodimer binding at the interferon-β enhancer.  Mass spectrometry has 
shown acetylation of the basic region of ATF2 at K339 (13).  Although this residue is not 
predicted to directly contact any residue in IRF3, acetylation of K339 in ATF2 could 
potentially alter either contacts with the DNA in the presence of IRF3 or the 
conformation of ATF2 and thus the positioning of the R345 side chain, thereby 
influencing the orientation preference at the enhancer.   
 In addition to asymmetric charge modifications in ATF2 and Jun, I have shown 
that the binding of HMGI can also influence the orientation preference of ATF2-Jun 
heterodimers at the interferon-β enhancer.   HMGI has been shown to play a pivotal role 
in the assembly and disassembly of the interferon-β enhanceosome (22).  Acetylation of 
HMGI on lysine 71 correlates with the recruitment of the full complement of 
transcription factors to the endogenous enhancer in Sendai-virus-infected HeLa cells, 
whereas deacetylation of lysine 71 followed by acetylation of lysine 65 precedes the 
disassembly of this complex (22).    
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Figure 5.3 Proposed interplay of heterodimer orientation, HMGI, HMGI acetylation the 
formation of ATF2-Jun-IRF3 complexes at the endogenous interferon-β enhancer.   Upper 
diagram: There are at least six alleles of the single human interferon-β gene in HeLa cells that are 
indicated by horizontal black lines.  Cells expressing heterodimers that favor the binding of Jun (cyan) 
to the left half-site (left diagram) are predicted to form less enhancer complexes than cells expressing 
heterodimers that favor the binding of Jun to the right half-site (right diagram).  Middle diagram: Cells 
expressing oppositely oriented heterodimers are predicted to form similar amounts of enhancer 
complexes in the presence of HMGI (purple oval).  Bottom diagram: In the presence of lysine 71-
acetylated HMGI, recruitment of HMGI to the composite ATF2-Jun-IRF3 site is predicted to be 
inhibited, resulting in different amounts of enhancer complexes and, consequently, different levels of 
interferon-β transcription depending on the orientation of heterodimer binding (compare left versus
right diagram).   
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 Although the recruitment of acetylated HMGI to the interferon-β enhancer occurs 
concomitantly with the recruitment of ATF2, Jun, and IRF3, efforts to detect ATF2-Jun-
IRF3-HMGI complexes have been elusive.  I have found that HMGI binds cooperatively 
with ATF2-Jun-IRF3 complexes at the interferon-β enhancer.  Various modifications of 
HMGI (K65Q, K65E, K71Q, K71E) had no measurable effect on the orientation 
preference of bATF2-bJun heterodimers and resulted is less efficient binding to the IFNb 
oligonucleotide in either the presence or absence of other proteins.  Further studies are 
required to determine the role of HMGI and HMGI modifications on interferon-β 
activation by ATF2, Jun, and IRF3 in vivo [Fig. 5.3]. 
 
 
III.  OUTLOOK 
 
 
 Using ATF2-Jun-IRF3 complexes as model system, further investigations into the 
significance of nucleoprotein structure in gene regulation are possible.  In particular, the 
techniques of single-cell qPCR analysis and single-molecule mRNA visualization allow 
determination of the role heterodimer orientation preference on steady-state and dynamic 
properties of gene expression. 
 
III.A.  Fine tuning “noisy” gene expression 
 
 
  In many circumstances, measurement of gene expression in a large population of 
cells does an excellent job in predicting average behavior.  At the single-cell level, 
however, you often see large cell-to-cell variability in gene expression (8, 12, 27). This 
heterogeneity can be tied to many important biological processes, such as the evolution of 
genetically identical organisms and the immunological response to viral infection (30).  
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Therefore, ensemble measurements of gene expression can potentially mask significant 
physiological differences between different populations of cells that have similar mean 
mRNA levels but very different variations from the mean.   This need for single-cell 
analyses has led to the development of a number of novel techniques that rely on 
automated technology to isolate and perform measurements on individual cells, including 
single-cell protein reporter assays (2, 4, 17, 20, 29, 40, 42, 43).  Protein reporter assays 
tend to add translational noise to the data generated as well as measurement noise due to 
cellular autofluorescence and other limiations of direct fluorescence assays.   
 To determine the noise, differential expression from different interferon-β alleles 
of human cultured cells can be measured used a common readout polymorphism of 
interferon-β.  Different allelic mRNAs differ by a single nucleotide and the amplified 
single cell PCR product is predicted to preserve their relative levels of expression within 
each cell.  Since factors such as viral load, transcription factor expression levels, 
signaling components, or polymerase activity should affect both alleles equally in a given 
cell, differential expression from different alleles in the same cell will represent noise 
intrinsically tied to the transcription process itself such as that associated with 
conformational variability in the nucleoprotein architecture at gene loci.  
 
III.A.i.  Role of heterodimer orientation in allele-specific transcription 
 
 My experimental model of un-oriented ATF2-Jun binding at sites of transcription 
which clearly favor a particular orientation begs the question: WHY?  Single-cell 
proteomic studies in yeast have revealed that proteins that are essential for responding to 
environmental or pathogenic stimuli tend to display high levels of cell-to-cell expression 
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variability.  In particular, genes which are responsive to factors such SAGA and 
SWI/SNF  that act on chromatin structure to reversibly convert inactive DNA to active 
DNA tend to encode proteins whose levels fluctuate considerably.   As suggested by 
Blake et al. (3) and Raser et al. (26), high noise is likely to be due, at least in part, to the 
introduction of a slow step into the production of mRNA, making the process more prone 
to bursts.   Therefore, it is my hypothesis that un-oriented ATF2-Jun binding may 
introduce an obligatory element of randomness to interferon-β gene expression following 
viral infection.  To test this, allele-to-allele variability of interferon-β mRNA expression 
can be measured in virally-infected HeLa cells over-expressing opposite oriented ATF2-
Jun heterodimers.    
 Two types of mRNA variability can be expected in this experimental system:  
cell-to-cell or “extrinsic” variability and within-cell or “intrinsic” variability.  Extrinsic 
variability may reflect 
T
differences in the state of each cell or its surrounding environment, 
whereas intrinsic variability may stem from the inherently chaotic nature of biomolecular 
events—such as a chance collision between two randomly moving proteins or erratic 
fluctuations in the conformation of a stretch of DNA.  Differences in the expression of 
the different alleles in the same cell can be assumed to be independent of extrinsic 
variability.  For example, if bi-directional ATF2-Jun binding underlies intrinsic gene 
expression variability, you would expect to see more correlation between the levels of 
allele 1 and allele 2 mRNA in cells expressing favorably-oriented complexes compared to 
cells expressing unfavorably-oriented complexes [Fig. 5.5].   
 
 
 
 
 133
 
 
 
 
 
 
 
Figure 5.4. Proposed effect of conformational variability in transcription factor-DNA complexes 
on intrinsic gene expression noise.  The expression of two different allelic variants of the interferon-β
(IFNB) gene will be detected by qPCR in single cells isolated by flow cytometry.  Extrinsic noise will 
be defined as the variation in expression of identical alleles due to differences between cells (this is 
represented by the total range of mRNA levels along the diagonal, dashed arrow), whereas the intrinsic 
noise will be defined as the variation in expression of two different alleles in the same cell (this is seen 
where data points for individual cells do not lie on the diagonal, solid arrow).  
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III.B  Visualization of single mRNA transcripts 
 
 
 The textbook model of gene transcription that most students and educators have 
become accustomed to learning and teaching usually involves a scenario that is assumed 
to proceed smoothly and uniformly over time.  However, recent work has revealed that 
many genes are expressed in a pulsating manner.  That is, the period of time in which a 
gene is considered “on” can include bursts of transcriptional activity and intervals of 
inactivity.   The most direct way to detect gene activation and inactivation is to directly 
monitor the mRNA produced from the gene at the resolution of single molecules.  Since 
the stability of mRNA is typically much lower than that of proteins, mRNA levels tend to 
reflect more accurately the state of a gene.  Pioneering work by the Singer laboratory has 
made possible the quantitation of mRNA expression at the single transcript level in living 
yeast.   In this approach, the mRNA transcript of interest bears a repeated sequence motif 
which binds to an ectopically expressed protein tagged with green fluorescent protein 
(GFP).    Then, the number of mRNA molecules can be reliably estimated by measuring 
the intensity of the fluorescent spots corresponding to mRNA-bound GFP molecules.   
 
III.B.i.  Role of heterodimer orientation in the kinetics of transcription 
 
 Interferon-β transcription has a strong stochastic element that results in large cell-
to-cell variability.  By observing the kinetics of mRNA expression in individual cells, the 
mechanism for how conformational variability in ATF2-Jun-IRF3 complexes contributes 
to the inherent randomness of gene activation can be elucidated.  Many phenomena have 
been offered as potential mechanisms underlying “transcriptional bursting,” however 
none have been critically tested.  By quantitating mRNA expression at the single 
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molecule level in cells expressing the previously described conformation-trapping 
proteins, investigation of the role of conformational heterogeneity in transcription factor 
complexes on the dynamics of gene expression is possible.  
 This general strategy can be used to compare the dynamics of interferon-β mRNA 
expression in virally-infected human cells expressing ATF2-Jun-IRF3 complexes 
predicted to have different conformational variations.  To do this, a previously 
established method for gene delivery in mammalian cells can be combined with the 
above-described mRNA detection method in yeast.  Specifically, retroviral gene delivery 
can be used to integrate the entire enhancer-promoter region of interferon-β upstream of a 
reporter gene bearing binding sites for GFP-tagged proteins into the genomes of cultured 
human cells.     These cells that stably express the reporter gene can then be transfected 
with plasmids expressing GFP-tagged proteins, ATF2, Jun, and IRF3 and virally infected.   
 It is predicted that if bursting is due to random fluctuations in interferon-β gene 
expression can be attributed to random changes in ATF2-Jun binding orientation, that 
cells transfected with heterodimers that only bind to DNA in the orientation that favors 
transcriptional activity will have a more uniform interferon-β expression pattern 
characterized by reduced frequencies of transcriptional bursting. Enhanceosome 
formation increases the rate of expression by an unknown mechanism.  Many phenomena 
such as chromatin remodeling, the unbinding and binding of transcription factors, and 
changes in DNA conformation have been offered as potential mechanisms underlying 
“transcriptional bursting,” however the subtle nature of these events has made critical 
testing of their roles impossible.   
 136
 Several groups have reported new methods for temporally tracking mRNA levels 
in single cells through the use of fluorescent protein which binds to non-coding regions of 
mRNA.  This technique can be used to determine the effect of different nucleoprotein 
conformations on the kinetics of interferon-β gene expression.   Specifically, confocal 
microscopy and its associated quantification software can be used to visualize and 
measure increases in fluorescence due to allele-specific interferon-β gene expression in 
virally infected cells predicted to have either wild-type or conformationally-trapped 
ATF2-Jun-IRF3-HMGI complexes bound to the enhancer.  It is predicted that, if oriented 
heterodimer binding is associated with a rate-limiting step in interferon-β transcription, 
the time it should take to achieve a particular level of mRNA expression will be 
decreased for gene loci bound by ATF2-Jun-IRF3-HMGI complexes that trap a particular 
conformation. 
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 Figure 5.5. Proposed effect of orientation on the kinetics of interferon-beta transcription.  Time 
required for the formation of the pre-initiation complexes is indicated by “T.” Differences in the 
orientation preference of ATF2(orange)-Jun(cyan) heterodimers are predicted to increase (indicated by 
red arrow) or decrease (indicated by green arrow) the time is takes for de novo transcriptional 
activation.  Heterodimer orientation preference can also influence the de-activation time (toff) and the re-
initiation time (ton) which can influence the ratio of active versus inactive complexes.  
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IV.  APPENDICES 
 
Preliminary work  
 
 A method for the quantification of allele-to-allele variability in interferon-β 
mRNA expression in primary dendritic cells using real-time PCR has been previously 
reported (12).   I have adapted this assay to the analysis of HeLa cells for the purpose of 
determining of the effect of transfected plasmids encoding ATF2 and Jun on allele-to-
allele variability in interferon-β transcription.   
 In order to detect allele-to-allele variability, it is necessary to distinguish the 
expression of mRNA from one allele from the expression of mRNA from another allele. 
Single nucleotide polymorphisms (SNPs) are naturally occurring sequence variations in 
the genome that can occur in one but not the other allele of any given gene, and can be 
used in order to determine the allelic origins of gene transcripts.  In order to determine 
the presence of SNPs in the coding region of the interferon-β gene, I PCR amplified the 
coding region of the interferon-β gene from either HeLa genomic DNA or cDNA 
synthesized from total mRNA isolated from virus infected HeLa cells and submitted the 
amplification products for DNA sequencing according to the following protocol: 
 
 Genomic DNA isolation from HeLa cells: 
 
 Washed HeLa cells twice in PBS and trypsinized.  Centrifuged for 5 min.   
 at 500 rpm.  Harvested genomic DNA from 4.4 X 106 HeLa cells with   
 DNeasy tissue kit; eluted with 400 μl buffer AE. 
 
  
 Purification of cDNA from virus-infected HeLa cells: 
 
 Purified cDNA from Sendai virus-infected HeLa cells with QiaQuick   
 columns from gel elution kit using PCR purification protocol; eluted with   
 50 μl buffer TE 
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 Amplification and Sequencing primers: 
 IFNB 5’:  5’-ATGACCAACAAGTGTCTCCTCC-3’  
 IFNB 3’: 5’-GATAGACATTAGCCAGGAGGTTC-3’ 
 
 qPCR reaction buffer: 
 8.1 μl template DNA 
 1.5 μl 10X ThermoPol buffer 
 1.5 μl DMSO 
 0.6 μl dNTP 
 1.5 μl 10 μM For 
 1.5 μl 10 μM Rev 
 0.3 μl Vent polymerase 
 
 Cycling conditions: 
 94°C for 1 min. 30 sec. 
 94°C for 30 sec. 
 57°C for 30 sec.  
 72°C for 3 min. 
 go to 2, 39 times 
 72°C for 10 min. 
 4°C forever 
 
 Sequencing revealed a T/C SNP in the coding region of interferon-β.  In order to 
determine the relative expression the interferon-β T allele from the interferon-β C allele 
in individual cells, I have applied adapted the previously described protocol (12) to the 
analysis of gene expression in individual virus-infected HeLa cells.  
 Virus-infection and cell-sorting: 
 
 Lysis buffer: 
 4 mM Magnesium acetate 
 0.05% NP-40 
 0.8 U/ml protector RNase inhibitor 
 
 Sorted 1 cell per well in round-bottom 96-well plates 
 
 Combined cDNA synthesis and qPCR 
 
 RT-qPCR primers: 
 GAPDH-Left  5’-AGCCACATCGCTCAGACAC-3’ 
 GAPDH-Right 5’-GCCCAATACGACCAAATCC-3’ 
  
 IFNB F  5’-GTCAGAAGCTCCTGTGGCAATTGAA-3’ 
 140
 IFNB R  3’-TTCTGGAACTGCTGCAGCTGCTTAA-3’ 
  
 Combined reverse transcriptase and amplification buffer: 
 5 μl 2X SYBR mix containing Taq polymerase (Roche) 
 0.05 μl 100 mM primer 1 
 0.05 μl 100 mM primer 2 
 0.1 μl Transcriptor reverse transcriptase (Roche) 
 
 Cycling conditions (10 μl reaction volume, 50 cycles): 
 pre-incubation:  65°C for 30 min., 95°C for 10 min 
 amplification:  95°C for 30 sec., 60°C for 30 sec., 72°C for 15 sec. 
 melting curve:  95°C for 5 sec., 55°C for 30 sec., 95°C (continuous) 
 cooling: 40°C for 10 sec. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6. qPCR analysis of mRNA expression in individual virus-infected HeLa cells.  HeLa cells 
were infected with Sendai virus for 6 hours and sorted by flow cytometry into individual wells of a 96-
well round-bottom plate containing 5 μl lysis buffer.  An equal volume of reaction mix containing 
reverse transcriptase, Taq polymerase, and gene-specific primers was added to each well.  Following 
pre-incubation for 30 minutes at 65°C to allow conversion of the mRNA into cDNA, 50 cycles of 
amplification were carried out.  Upper left: Relative GAPDH transcript level was plotted for each cell. 
Reactions containing the above described components (wells 25-60, white bars) produced amplified 
product.  Reactions that did not include reverse transcriptase (wells 1-24) did not amplify, indicating 
that genomic DNA is not measured under these conditions.  Reactions that included reverse 
transcriptase reaction buffer (well 61-96 well, dark bars) showed inhibited amplification.  Upper right:
Histogram of number of cells as a function of discrete ranges of GAPDH transcript levels for wells 25-
60.  Bottom left: Relative interferon-β (IFNB) transcript level was plotted for each cell.  Reactions that 
did not include reverse transcriptase (wells 1-24) did not produce amplification.  Reactions containing 
the above described components (wells 25-96, white bars) produced amplified product.  Bottom right:
Histogram of number of cells as a function of discrete ranges of IFNB transcript levels for wells 25-96. 
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